Are you a healthcare organization accelerating your sustainable practices and seeking formal recognition?
Discover how Joint Commission International (JCI) and the Geneva Sustainable Centre (GSC) can support you on your journey toward sustainable healthcare.
For more information, please scan the QR code.
Two increasingly significant phenomena have been shaping the medical landscape across the Arab world. Although they influence the region as a whole, their effects vary considerably between the Gulf and many other Arab countries.
The first phenomenon is the global recognition of Arab doctors, whose outstanding achievements, whether through pioneering medical procedures that led to cures for previously untreatable conditions or through academic contributions that earned them high international rankings, highlight their exceptional skills. A recent example is Emirati physician Dr. Hamed bin Harmel Al Shamsi, who was appointed as a visiting professor at Harvard University.
The second is the growing trend of physician migration from low-income Arab countries to wealthier nations. While this benefits the healthcare systems of the host countries, it creates a significant gap in the healthcare infrastructure of their home countries, one that is often difficult to fill.
This issue sparked debate in Egypt when Alexandria University announced 117 vacancies for resident doctors in its university hospitals. The news raised questions about why so many doctors are leaving the country. The university responded by noting that many are seeking better opportunities abroad that match their ambitions.
Our Arab doctors, who have always adhered to strict professional ethics, regulations, and standards of excellence, seem no longer bound by their national borders. Regional and global opportunities appeal to them, and the prospect of expanding their success drives them forward, especially when their competence is recognized and valued wherever they go. And indeed, wherever they go, they excel.
The Publisher
Publisher Arab Health Media Communication
President Simon Chammas schammas@tahmag.com
Executive Vice President Mirna Khairallah mirna@tahmag.com
Senior Editor Elham Najem editorial@tahmag.com
Content Executive Jessica Achkar editorial@tahmag.com
Editors Aline Debes, Mark Steven, Don Karn, Andrew Weichert, Colette Semaan, Abbas Moussa
Senior Director of Content Marketing Jessie Chlela jessie@tahmag.com
Creative Director Rania Khalil rania@tahmag.com
Business Development Manager Wadih Chammas wadih@tahmag.com
IT Manager Elie Yammine elie@tahmag.com
Photographer Hanna Nehme
Advertising advertising@thearabhospital.com
OFFICES
IHMC, Cyprus +357 96 158661
Dubai
Expert Media Communication Services-FZCO
Dubai Silicone Oasis +971 50 2971007
Printing
Distribution KSA - UAE - OMAN - TURKEY
LEBANON - JORDAN - KUWAIT
BAHRAIN - QATAR - EGYPT
All images from shutterstock© unless provided by clients .
All rights reserved by the HOSPITALS magazine. No part of this publication can be reproduced in any form without prior permission in writting from the publisher.
28
Pioneering Emirati Oncologist Prof. Humaid Al Shamsi
Joins Harvard and Dana-Farber, 46 Green Hospitals: Sustainable healthcare management is essential, not optional
Climate Impacts on Health: From Heatwaves to Infectious Diseases
Farewell to Cellulite: Your Guide to the Leading Techniques
8 Successful Implant of AVEIRTM Leadless Pacemaker in Morocco, Groundbreaking technology brings minimally invasive, advanced treatment for cardiac arrhythmias to the region
22 First-of-its-kind art and medicine project “public health” launched by the American University of Beirut Medical Center in collaboration with TAP (Temporary Art Platform)
92 Hub71 Startup, Ovasave, Raises $1.2m Pre-Seed Round to Transform Fertility and Hormonal Care Across MENA
40 Green Hospitals: Sustainable healthcare management is essential, not optional
54 Climate Impacts on Health: From Heatwaves to Infectious Diseases
68 Farewell to Cellulite: Your Guide to the Leading Techniques and Treatments
88 Laboratory Safety: A Legal Obligation & Global Standard
48 UChicago Medicine: Chemo-immunotherapy approach shows potential benefit in patients with advanced HPVnegative head and neck cancer
50 1st Human Bladder Transplant Performed at UCLA Health
52 First Fully robotic heart transplant surgery in U.S. performed at Baylor St. Luke's Medical Center
60 Innovative Applications Boost IVF Success Rates at Acıbadem
78 Maximum Safety in Infection Control After Prosthesis Surgery at Acıbadem: A World-Class Approach
44 Dr. Walid Honeineh, General Practitioner at Clemenceau Medical Center in Beirut
64 Mona Mirza, Founder & CEO at Biolite Aesthetic Clinic, AURA 3D Imaging System – Biolite Clinic
72 Dr. Fadi Hamadani, Plastic, Cosmetic, and Reconstructive Surgeon
58 Steam (REZUM) Over Scalpel: Al-Ahli Hospital’s Breakthrough in Treating Enlarged Prostate with Innovation, Compassion, and Confidence
76 Redefining Precision in Gastroenterology: Advanced ERCP with SPYGLASSTM at Al-Ahli Hospital
82 Rhinoplasty Between Health and Aesthetic Needs
94 The Silent Crisis: Why Healthcare Deserves to Be Our Top Priority
technology brings minimally invasive, advanced treatment for cardiac arrhythmias
Abbott announced that Clinique Jerrada Oasis successfully implanted the AVEIR™ leadless pacemaker in patients with cardiac arrhythmias. This first-of-its-kind procedure in Morocco was performed under the supervision of Professor Abdelhamid Moustaghfir, a renowned expert in interventional cardiology, and marks a major milestone in the advancement of cardiac care in the country.
Approved by the U.S. Food and Drug Administration (FDA) in March 2022, the AVEIR™ leadless pacemaker is designed to treat individuals experiencing slow or irregular heart rhythms. The device is implanted directly into the heart’s chamber using a minimally invasive, catheter-based procedure, without the need for surgical incisions or traditional pacemaker leads. This approach significantly reduces the risk of lead and pacemaker pocket complications and allows for a quicker recovery period.
“The implantation of AVEIR™ for the first time in Africa reflects our commitment to addressing healthcare needs through the best available technologies,” emphasized Professor Abdelhamid Moustaghfir. “This innovative technology offers a discreet and reliable solution for patients suffering from cardiac arrhythmia, while ensuring good protection against fainting and other rhythm disorders.”
“Today, Morocco reaches a new milestone in cardiovascular care”, said Adele Jamali, General Manager for Abbott’s cardiac rhythm management business in the Middle East and Africa. “By bringing AVEIR™ to the region, in collaboration with our distributor Vicenne through its subsidiary Soma Medical, we aim to expand access to innovative technologies that not only meet patients’ medical needs, but also empower them to live healthier, fuller lives.”
People who experience a slower-thannormal heart rate may receive a pacemaker to help restore a more normal heart rate. Unlike
THIS BREAKTHROUGH TECHNOLOGY
ENABLES THE WORLD'S FIRST BEATTO-BEAT, WIRELESS COMMUNICATION & SYNCHRONIZATION BETWEEN TWO LEADLESS PACEMAKERS, WHICH ARE SMALLER THAN A AAA BATTERY.
traditional pacemakers, leadless pacemakers do not require physicians to make an incision in the chest to implant the device or insulated wires – known as leads – that deliver the electrical energy to the heart. Instead, the device is implanted directly into the heart’s chamber via a minimally invasive catheter-based procedure and eliminates the need for cardiac leads. This offers a less restrictive recovery period and reduced leads and pocket complications.
Among the key advantages that differentiate AVEIR™ from other leadless pacemakers, is its ability to be retrieved at any time depending on the patient’s future needs or therapies. Besides, it can be upgraded to a dual chamber leadless system if the patient’s condition requires that.
A n exc e ptio n al g ro u p devote d to
ACIBADEM MOBIL
provides emergency and home care services outside of the hospital.
ACIBADEM APLUS
addresses the hygiene and catering requirements of the hospitals.
ACIBADEM HEALTH POINT ensures continuous support for patients from their arrival at Istanbul Airport until they return home, guiding them through their entire healthcare journey in Türkiye.
ACIBADEM TECHNOLOGY
develops and improves inhouse softwares including Hospital Information System and healthcare command center.
ACIBADEM UNIVERSITY
trains healthcare students to be future healthcare professionals.
ACIBADEM LABMED
offers a wide range of services including pathology, food control, stem cell and cord blood bank within the laboratory framework.
develops turnkey hospital establishment projects.
Step into a world where healthcare is not just a service, but a carefully designed ecosystem centered around Patient Safety and Patient Satisfaction – Welcome to ACIBADEM. At the forefront of innovative medical care, ACIBADEM's healthcare model is a testament to its unwavering commitment to excellence. Every facet of the healthcare journey is seamlessly integrated, with ACIBADEM collaborating with its supporting institutions at every step to mitigate risks and ensure service quality that aligns with ACIBADEM standards. Embark on a journey of cutting-edge medical services that transcend borders, as ACIBADEM extends its reach across Türkiye, Bulgaria, Macedonia, Serbia, and the Netherlands. Experience healthcare like never before, where your well-being takes center stage.
Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024–25” rankings. As a global leader in healthcare, we offer a full range of services to patients from around the world. Whether we’re providing clinical services in your region via video visits or at our renowned medical center, our mission remains unchanged: to give patients access to excellence in healthcare—wherever they may be. Located in iconic Beverly Hills, Cedars-Sinai blends cutting-edge medicine in a vibrant setting known for its rich culture, famous landmarks and year-round warm weather—making it a leading destination for international patients seeking world-class treatment.
•
•
•
•
•
The American University of Beirut Medical Center (AUBMC), in collaboration with TAP (Temporary Art Platform), launched “public health,” an art and medicine project which is a first-of-its-kind initiative in Lebanon and the region that consists of contemporary art interventions for the Halim and Aida Daniel Academic and Clinical Center (ACC) at AUBMC. The launch was held in the presence of AUB President Fadlo R. Khuri, AUB Medical Center Director Joseph Otayek, Associate Vice President for Academic Centers, Development, and External Affairs Ali Taher, TAP Founder and Curator Amanda Abi Khalil, along with esteemed AUB and AUBMC faculty and leadership.
“Public health” is a series of site-specific commissions to eight contemporary artists who were invited in 2017 to consider and challenge the medical center setting as a nonplace, defined by anthropologist Marc Augé as a space individuals pass through without forming lasting social connections or a sense of belonging.
Initiated in 2017 and brought to life through the vision of Curator Amanda Abi Khalil and Associate Curator Nour Osseiran of TAP, the project unveiled six artworks by Tamara Al-Samerraei, Catherine Cattaruzza, Hatem Imam, and Lara Tabet, as well as artist duos Rayya and Zeina Badran, and Nadim Mishlawi and Sharif Sehnaoui. The works explored the unique sounds, bodies, and stories that inhabit AUBMC’s environment. Their site-specific works reframed the medical center’s space as one of reflection, interaction, and emotional resonance.
By embedding contemporary art within a clinical setting, “public health” promotes medical-oriented research in the art field, fosters innovative collaborations between artists, curators, and healthcare professionals, and grants patients and visitors access
to meaningful artistic engagement in an environment often associated with stress and routine.
President Fadlo R. Khuri said, “Today, we are not just launching a collection of art. We are renewing a promise. A promise to build a healthcare system that is compassionate, patient-centered, engaging, and a genuinely human place to receive care. I want to thank everyone who helped bring this vision to life: our partners at TAP, the artists, our generous donors, and, of course, the leadership team at AUBMC, thank you for believing in this project from the start.”
"This is not art as an ornament. This is art as infrastructure, as a vital, integrated part of how we imagine healing. Through intentional and inspired interventions, through art, we can reclaim hospitals as places of meaning, of comfort, of connection," Ali Taher added.
“By inviting artists to engage with the medical center as a site, not just a backdrop, ‘public health’ opens up a field of inquiry that is both urgent and under-explored. The project reveals how contemporary art can intervene meaningfully in the hospital environment: from participatory processes with staff and patients, to sensory and spatial interventions that challenge how we experience care,” explained Amanda Abi Khalil
This idea was instigated by Dina Zameli at the inauguration of President Fadlo R. Khuri and was generously supported by AUBMC, Hamzah Dayyeh, Nafiz Mustafa Jundi, Michel Khallouf, Elie Khalil Khoury, Henrietta Abela Nammour, Mohamad Ali and Dina Zameli, and Commercial Insurance.
As a milestone in AUBMC’s legacy, this project highlights the institution’s commitment not only to medical excellence, but also to cultural innovation and community connection, reaffirming AUBMC’s role as a pioneer in healthcare.
TODAY, WE ARE NOT JUST LAUNCHING A COLLECTION OF ART. WE ARE RENEWING A PROMISE. A PROMISE TO BUILD A HEALTHCARE SYSTEM THAT IS COMPASSIONATE, PATIENT-CENTERED, ENGAGING, AND A GENUINELY HUMAN PLACE TO RECEIVE CARE. I WANT TO THANK EVERYONE WHO HELPED BRING THIS VISION TO LIFE: OUR PARTNERS AT TAP, THE ARTISTS, OUR GENEROUS DONORS, AND, OF COURSE, THE LEADERSHIP TEAM AT AUBMC, THANK YOU FOR BELIEVING IN THIS PROJECT FROM THE START.
PRESIDENT FADLO R. KHURI
April 8-11, 2025
Shanghai, China
Sept. 26-29, 2025
Guangzhou, China
Exhibitors
In a historic milestone that underscores the rapid advancement of the medical and scientific sectors in the United Arab Emirates, Professor Humaid Bin Harmel Al Shamsi has achieved prestigious international recognition by being appointed a Visiting Professor at the renowned Harvard Medical School, and a
Visiting Scientist at Dana-Farber Cancer Institute in Boston. On this occasion, 'Hospitals' Magazine had the honor of conducting an in-depth interview with Professor Al Shamsi to explore the significance of this achievement and how he envisions leveraging it to enhance scientific research and healthcare in the UAE.
THIS IS THE KIND OF OPPORTUNITY THAT COMES ONLY ONCE IN A LIFETIME FOR A PHYSICIAN.
Could you tell us more about this opportunity and what responsibilities it entails?
This is the kind of opportunity that comes only once in a lifetime for a physician. It is the culmination of decades of dedication and hard work in the field of oncology. Being named a Visiting Professor at Harvard Medical School, ranked the top medical school globally, and a Visiting Scientist at Dana-Farber signifies my integration into the academic and research fabric of two of the world’s most respected medical institutions. My responsibilities
include participating in strategic research committees that shape the future of cancer care, particularly for patients in the Gulf region. I will also collaborate with global leaders in the fields of immunotherapy and genetic research, contribute to scientific discussions, and review clinical studies. Beyond the formal responsibilities, I also carry an unwritten duty: representing the UAE and voicing the needs of our region on the global scientific stage.
How were you nominated or selected for these prestigious roles?
MY RESPONSIBILITIES INCLUDE PARTICIPATING IN STRATEGIC RESEARCH COMMITTEES THAT SHAPE THE FUTURE OF CANCER CARE, PARTICULARLY FOR PATIENTS IN THE GULF REGION.
My nomination came after a long and rigorous academic and professional journey. It was not accidental, but rather built on a solid body of research, over 160 peer-reviewed studies published in leading journals such as JAMA and The Lancet. These works addressed previously overlooked topics in our region, including earlyonset cancer, genetic diversity in oncology, and the unique healthcare challenges in the Middle East. In parallel, I led several national initiatives, including the establishment of the UAE’s first integrated pediatric bone marrow transplant unit, the creation of a national fellowship program in hematology and oncology, and oversight of the largest cancer treatment network in the UAE.
My consistent presence at international conferences and the academic partnerships I’ve cultivated with institutions in North America and Europe also played a role. As a result, I became the first Emirati and GCC physician appointed as a Visiting Professor at Harvard and a Visiting Scientist at Dana-Farber. This honor comes with the responsibility to turn personal success into collective progress for students, researchers, and patients across the Arab world.
What goals do you hope to achieve during your time at Harvard and Dana-Farber?
My primary aim is to transform this personal milestone into a platform for knowledge transfer. My goals include:
• Contributing to research on early-onset cancer in young adults, particularly given the abnormal incidence rates in our region.
• Building a long-term research collaboration between Harvard, Dana-Farber, and medical institutions in the UAE.
• Creating formal pathways for Emirati doctors to join fellowship and advanced training programs at these institutions.
• Studying the genetic and environmental factors influencing treatment responses in our population, and developing personalized care solutions.
How do you envision this experience enriching your clinical practice and future research?
My time at Dana-Farber will deeply enrich my medical practice and research through exposure to a cutting-edge scientific environment that integrates clinical data, genetic insights, and digital modeling to create precision-targeted therapies. It will reshape my approach to care and equip me with advanced tools, both practical and intellectual, that I can bring back to the UAE. I also plan to expand genetic screening as a predictive tool, contribute to the establishment of a national cancer research center, and embed innovation into everyday clinical practice. The goal is to develop a UAE-based model of precision medicine and integrated cancer care.
As one of the pioneers of oncology in the UAE, what key initiatives have you led?
I’ve had the privilege of leading several impactful initiatives, including:
• Establishing the UAE’s first national bone marrow transplant program, offering treatments previously only available abroad.
• Launching the country’s first national fellowship in hematology and oncology, designed to train physicians to international standards.
• Developing the largest cancer treatment network in the UAE through Burjeel Cancer Institute, with nationwide reach.
• Securing the first European accreditation for cancer care in the UAE from the European Society for Medical Oncology (ESMO).
• Leading the first comprehensive cancer research project in the Arab world through co-authoring the book Cancer in the Arab World, which has become a key reference.
• Spearheading awareness campaigns and promoting early detection through social media platforms.
• Representing the UAE on prestigious international panels, including the Global Lung Cancer Policy Network, and now, as a Visiting Professor at Harvard.
How have you contributed to building local capacity in oncology?
My contribution to capacity-building has taken several forms:
MY CONSISTENT PRESENCE AT INTERNATIONAL CONFERENCES AND THE ACADEMIC PARTNERSHIPS I’VE CULTIVATED WITH INSTITUTIONS IN NORTH AMERICA AND EUROPE ALSO PLAYED A ROLE. AS A RESULT, I BECAME THE FIRST EMIRATI AND GCC PHYSICIAN APPOINTED AS A VISITING PROFESSOR AT HARVARD AND A VISITING SCIENTIST AT DANA-FARBER. THIS HONOR COMES WITH THE RESPONSIBILITY TO TURN PERSONAL SUCCESS INTO COLLECTIVE PROGRESS FOR STUDENTS, RESEARCHERS, AND PATIENTS ACROSS THE ARAB WORLD.
• Hands-on training and clinical supervision of medical students and residents, emphasizing both practical skills and compassionate care.
• Co-founding the UAE’s first nationally accredited fellowship program in oncology and hematology, tailored to local healthcare needs while adhering to global standards.
• Fostering academic and research culture through teaching roles, organizing monthly research forums, and encouraging medical students to engage in evidence-based inquiry.
• Creating bridges with world-leading
institutions in North America and Europe, opening opportunities for knowledge exchange and international training.
• Empowering the next generation of Emirati physicians through mentorship, inspiring them to lead and innovate in oncology.
What critical advancements are needed to improve cancer care in the UAE?
Key priorities for the future include:
• Integrating AI into diagnostic imaging to enhance accuracy, speed, and reduce physician workload.
WE ACHIEVED TWO GUINNESS RECORDS, THE MOST AWARENESS RIBBONS MADE IN ONE HOUR (2,828 RIBBONS) AND THE LARGEST CANCER AWARENESS RIBBON IN THE WORLD.
In recognition of Prof. Humaid Al Shamsi’s appointment as Visiting Professor at Harvard Medical School, the first Gulf national to earn this prestigious academic title, a distinguished celebration was held at the iconic Burj Al Arab Hotel in Dubai. The event was attended by prominent sheikhs, dignitaries, leading figures in the medical sector, and members of the media from both within the UAE and abroad. Hospitals Magazine had the honor of being invited to this exclusive gathering, represented by its publisher, Mr. Simon Chammas. The ceremony highlighted the significance of this achievement, which reflects the academic excellence of Emirati physicians recognized by the world’s most esteemed institutions. In his remarks, Mr. Chammas praised Professor Al Shamsi’s unwavering dedication and competence, stating that his determination has not only propelled him to global prominence, but also helped elevate Arab healthcare to new heights.
• Making genetic testing a routine part of personalized treatment planning.
• Developing a national cancer outcomes registry to track recovery, relapse, and complications post-treatment, which is vital for data-driven decisions.
• Localizing the production and application of advanced cellular therapies such as CAR-T, including workforce training and lab infrastructure.
Have you participated in public awareness campaigns? What has been their impact?
Public education is a cornerstone of my professional mission. I have led and overseen several national campaigns, some of which entered the Guinness World Records. Among the most notable:
• The “Pink October” breast cancer awareness campaign, featuring free screenings and educational events.
• The “Check Early” initiative to promote early screening for various cancers.
We achieved two Guinness records, the most awareness ribbons made in one hour (2,828 ribbons) and the largest cancer awareness ribbon in the world. These efforts significantly boosted early screening rates, normalized conversations around cancer, and fostered a strong culture of community engagement and volunteerism.
How do you plan to leverage your current experience to improve cancer treatment in the UAE?
My experience at Harvard and Dana-Farber is a once-in-a-lifetime opportunity to immerse myself in one of the most advanced clinical and research environments globally.
More importantly, it’s a chance to transform this academic honor into a catalyst for systemic progress in the UAE.
My five-part strategy includes:
• Adapting Dana-Farber’s advanced care models for implementation in the UAE.
• Establishing a national cancer research center with international partnerships.
• Training healthcare providers in the latest treatment protocols.
• Accelerating the integration of precision medicine into routine care.
Developing a sustainable academic collaboration framework between Harvard and UAE institutions to ensure continuity in training and knowledge exchange.
What are the major global challenges facing cancer care today?
The key challenges include:
• The disparity in access to treatment between developed and developing nations.
• The escalating costs of novel therapies, which are often unsustainable for healthcare systems.
• The lack of comprehensive data from regions like the Middle East and Africa.
• Patients’ reluctance to seek treatment.
• Misinformation about cancer and its treatments on social media platforms.
What is your message to young doctors and researchers?
Drawing from more than two decades of experience, my message is simple yet profound. Create your own opportunities through perseverance and initiative. Let the patient always be your compass, the essence of medicine lies in humanity. Never stop learning.
MY TIME AT DANAFARBER WILL DEEPLY ENRICH MY MEDICAL PRACTICE AND RESEARCH THROUGH EXPOSURE TO A CUTTINGEDGE SCIENTIFIC ENVIRONMENT THAT INTEGRATES CLINICAL DATA, GENETIC INSIGHTS, AND DIGITAL MODELING TO CREATE PRECISIONTARGETED THERAPIES. IT WILL RESHAPE MY APPROACH TO CARE AND EQUIP ME WITH ADVANCED TOOLS, BOTH PRACTICAL AND INTELLECTUAL, THAT I CAN BRING BACK TO THE UAE.
Failure is the prelude to success. Choose your mentors wisely, but be original. Define your mission before your résumé. Dare to dream boldly. Our future lies in your hands.
How can the UAE lead cancer research in the region and beyond?
The UAE has the potential to become a regional and even global hub for cancer research, particularly in clinical trials and precision medicine. This is made possible by unparalleled government support for long-term research funding, state-of-the-art infrastructure, and a highly diverse population that enables the study of genetic variability. Strengthening international partnerships and training national researchers are also essential. These steps have already begun through fellowship programs and clinical research units. We are working toward building a national oncology database and a
regional innovation platform. The UAE is not just catching up, it’s ready to lead.
What achievement are you most proud of?
Of all my accomplishments, I am most proud of establishing the UAE’s first comprehensive bone marrow transplant program for children and adults. We’ve completed over 180 successful transplants with a 98% success rate, one of the highest in the world. This initiative emerged as a national imperative during the COVID-19 pandemic, when overseas travel for treatment was no longer an option. We developed a world-class unit, trained Emirati medical teams, implemented cutting-edge protocols, and built a post-transplant care network. This is not just a statistic, it’s a beacon of hope for patients and their families, and a living embodiment of the UAE’s leadership vision that places human dignity above all.
BECAUSE AFRICA FACES A GROWING CANCER CRISIS, WITH LIMITED EARLY DETECTION AND TREATMENT OPTIONS. MANY PATIENTS ARE DIAGNOSED TOO LATE, OR NOT AT ALL. CHILDREN, WOMEN, AND MEN ARE DYING IN SILENCE, THEIR STORIES UNTOLD SIMPLY BECAUSE THEY WERE BORN FAR FROM OPPORTUNITY.
What are your aspirations for the future?
Despite my academic and professional milestones, my greatest dream is rooted in humanity, to establish a fully integrated, charitable cancer center in an African nation, where treatment is entirely free. This isn’t about expanding my career. It’s about my core belief that healthcare is a fundamental right, not a privilege, and that dignity should never depend on one’s ability to pay.
Because Africa faces a growing cancer crisis, with limited early detection and treatment options. Many patients are diagnosed too late, or not at all. Children, women, and men are dying in silence, their stories untold simply because they were born far from opportunity.
How do you plan to make this dream a reality?
Although building a charitable cancer center in Africa is a monumental task, I am determined to make it happen.
I’m forging partnerships with public and private entities both locally and globally, developing a sustainable funding model based on donations and grants, and engaging African ministries of health to secure logistical support and land. I also aim to rally the Arab and global medical communities to volunteer their expertise for this humanitarian mission.
Because medicine, at its core, is a calling, not just a career. True success is not measured by awards or titles, but by the lives we save without expecting anything in return.
I believe that when the intent is genuine, God opens doors. And this project is one I approach not as a professor or an executive, but as a physician, with an open heart.
OF ALL MY ACCOMPLISHMENTS, I AM MOST PROUD OF ESTABLISHING THE UAE’S FIRST COMPREHENSIVE BONE MARROW TRANSPLANT PROGRAM FOR CHILDREN AND ADULTS. WE’VE COMPLETED OVER 180 SUCCESSFUL TRANSPLANTS WITH A 98% SUCCESS RATE, ONE OF THE HIGHEST IN THE WORLD. THIS INITIATIVE EMERGED AS A NATIONAL IMPERATIVE DURING THE COVID-19 PANDEMIC, WHEN OVERSEAS TRAVEL FOR TREATMENT WAS NO LONGER AN OPTION. WE DEVELOPED A WORLDCLASS UNIT, TRAINED EMIRATI MEDICAL TEAMS, IMPLEMENTED CUTTING-EDGE PROTOCOLS, AND BUILT A POSTTRANSPLANT CARE NETWORK.
The expansion of medical practices and the significant evolution of the healthcare sector have demonstrated that environmental factors impact healthcare, just as healthcare influences the environment. Experts agree that any effort to achieve environmental sustainability in the healthcare sector must begin here. Developing an advanced hospital model is key to enabling healthcare centers to transition into environmentally friendly institutions.
Another important observation is that healthcare was often overlooked in discussions on reducing environmental impact. However, over time, it has become increasingly clear that healthcare is the most critical field in which we can work to achieve greater sustainability. This realization has led to the emergence of a new concept in sustainable medical practice: green hospitals. This shift toward a more environmentally friendly healthcare system is no longer a luxury or a modern aesthetic; it is a necessity. When we examine the core of medical practice and its impact beyond hospital walls, including social, operational, and financial dimensions, it becomes undeniably clear that adopting eco-friendly practices lies at the heart of healthcare operations. The primary goal is human health, which begins with the surrounding community, the environment, and daily lifestyle. Preventing illness before it starts with preserving the environment.
As Janvi Solanki, Vice President of Clinical Programs at Humber River Health in Toronto, Canada, puts it: “Sustainability is not just a goal, it’s a responsibility.” She adds, “Every decision, from patient care to operations, must consider its environmental impact.”
The concept of a green hospital is crucial for promoting sustainable development in the healthcare sector. The goal is to minimize the environmental impact of hospitalization while enhancing the health and well-being of both
patients and staff. This objective is being actively pursued and is included in the United Nations Sustainable Development Goals (SDGs).
The healthcare sector, designed to protect health, ironically contributes to environmental pollution that harms it. This highlights the critical need for healthcare institutions to embrace ecofriendly practices. Sustainability is now a global priority focused on efficient resource use and widespread social recognition.
Key elements in achieving green hospital certification include integrating renewable energy sources, adopting innovative practices, utilizing smart building systems, and striking a balance between the benefits and challenges of implementation. Environmental sustainability criteria assess how hospitals minimize resource consumption and carbon footprint while maintaining high-quality patient care and staff satisfaction. Around the world, more healthcare centers are pursuing environmental certifications, redesigning their operations, creating green operating rooms, and reducing waste. But this transformation requires significant effort and planning. Hospitals face unique challenges due to their continuous operation; unlike offices or factories, they can’t “shut down,” making energy demands constant, even at night.
The Global Green and Healthy Hospitals (GGHH) agenda seeks to replace harmful chemicals, improve waste management, enhance energy efficiency, reduce water consumption, and design greener facilities. These actions have direct effects, such as reducing tons of CO₂ emissions. The philosophy behind it: “The health of people and the planet are inseparable.”
A green hospital prioritizes three key elements: environmental protection, agility, and digitization. This approach ensures sustainability in all operations, including waste reduction and efficient infrastructure.
For example, one hospital uses ORCA food waste digesters to turn organic waste into liquid, cutting greenhouse gas emissions. Its kitchen staff prepares 80% of meals fresh onsite, vacuum-seals leftovers, and favors reusable items. As hospitals recognize their environmental impact, global networks are emerging to reform healthcare practices and promote proper medical waste disposal, while facilities upgrade to meet green standards. Operational needs often create chances for green enhancements.
Successful examples of eco-friendly hospitals include the installation of photovoltaic panels, which save up to 25% of energy use. In the future, these systems could also power electric vehicle (EV) chargers or fully meet the hospital’s energy needs. Transitioning to energy-efficient systems is critical. Technologies such as LED lighting, smart building systems, and renewable energy sources can significantly reduce a hospital’s carbon emissions, with some reductions reaching up to 60%.
Key strategies include upgrading infrastructure, enhancing energy efficiency, and integrating renewable energy to reduce greenhouse gas emissions. Ensuring that healthcare systems like heating, cooling, lighting, and water operate efficiently is vital for a healing environment. Waste management, a newer research area in healthcare, is also important because hospitals generate significant waste, especially from operating rooms. Effective sorting, recycling, and innovative techniques can mitigate medical waste and environmental impact. Sustainable purchasing of eco-friendly medical supplies and food can further lower the ecological footprint. Even choosing the right window glass is essential for optimizing energy use and temperature control.
Healthcare buildings (HBs) operate continuously and are crucial for society. Regular assessment of Indoor Environmental Quality (IEQ) is vital for patient recovery, involving air quality monitoring and advanced filtration to reduce airborne pollutants like volatile organic compounds (VOCs) from paints and furnishings. Additionally, green building design,
which includes natural lighting and sustainable materials, enhances energy efficiency and fosters healing environments.
In the UK, the NHS is working to reduce the environmental impact of inhalers, which significantly contribute to their carbon footprint. By switching from pressurized metered-dose inhalers to dry powder inhalers, they aim to cut carbon emissions by 58 kilotons annually.
Hospitals around the world are adopting similar innovative practices to go green, without compromising patient care. As awareness of climate change grows, the shift toward green hospitals is expected to accelerate.
The healthcare sector faces the challenge of balancing its life-saving mission with its environmental impact. As the saying goes, hospitals must heal both people and the planet.
Climate change threatens public health, making healthcare institutions crucial for environmental stewardship. Green hospitals reduce ecological impact and promote sustainability in their communities. Sustainable healthcare buildings minimize natural resource use, support public health, and reduce pollution while boosting occupant health and well-being
Smart healthcare buildings now use advanced technology and building management systems to improve patient care, operational efficiency, and building performance.
The benefits of green hospitals go beyond environmental protection. Studies have shown that they can improve patient outcomes, reduce operational costs, and increase staff satisfaction.
Green hospitals focus on sustainability in healthcare. They use eco-friendly design strategies in new and renovated projects, aiming to reduce their environmental impact while providing quality care. This shift signifies a new approach to healthcare delivery, establishing sustainable practices as essential for responsible healthcare leadership. Green hospitals exemplify sustainable development, showing that environmental responsibility aligns with healthcare excellence. By focusing on design, resource efficiency, and community well-being, they prove we can protect the planet while providing high-quality care.
Walid Honeineh,
Medicine is undergoing a significant paradigm shift towards prevention and early detection today. In this context, "Hospitals" magazine interviewed Dr. Walid Honeineh, General Practitioner at Clemenceau Medical Center in Beirut, to highlight one of the center's prominent initiatives: the Premier Executive Health Check. The discussion explored the program's structure, clarified how it transcends conventional medical examinations, and underscored its crucial contribution to elevating community health awareness.
What is the Premier Executive Health Check program offered by CMC Beirut for early detection of silent diseases, designed to fit the demanding schedules of busy professionals?
Clemenceau Medical Center in Beirut proudly offers Premier Executive Health Check for the Early Detection of Silent Diseases, reflecting the principle that “an ounce of prevention is worth a pound of cure.”
The program includes a wide range of precise tests designed for the early detection of health problems.
For women, the program includes mammography and ultrasound for any woman aged 40 and above, along with a cervical smear (Pap test) to prevent abnormal cells or tumor development. The program also features a comprehensive eye and retina examination, intraocular pressure measurement, and an audiogram (hearing test).
For men, the program includes an abdominal and pelvic ultrasound to check prostate size and its impact on the bladder. If the patient is young and there are no specific concerns, some tests may be adjusted or removed from the program to suit the individual case. Additionally, colonoscopy from the age of 45 for both sexes is of utmost importance for detecting any polyps or masses in the colon that could develop into a tumor if left untreated.
• Laboratory studies for a complete blood count, urinalysis, and evaluation of blood chemistries, kidney function, fasting blood sugar, liver function tests, and thyroid function tests.
• Lipid evaluation was obtained through a thorough assessment of cholesterol levels.
• Hemoglobin A1C (blood sugar storage test) and urine microalbumin (for diabetes mellitus).
CLEMENCEAU
MEDICAL CENTER’S PREMIER EXECUTIVE HEALTH CHECK SURPASSES TRADITIONAL ROUTINE EVALUATIONS IN SCOPE AND DEPTH. WHEREAS STANDARD CHECKUPS TYPICALLY TARGET A SINGLE ORGAN SYSTEM OR FOCUS, SUCH AS BASIC BLOOD TESTS OR A GENERAL PHYSICAL EXAM, THE COMPREHENSIVE PROGRAM ADOPTS A MULTISYSTEM, INTEGRATED DIAGNOSTIC APPROACH.
• Cancer screening: Carcinoembryonic Antigen (CEA) and CA-125 (for tumor detection in women).
• Prostate-Specific Antigen: to detect prostate cancer or prostate enlargement in men over the age of 40.
Cardiac Evaluation
• Cardiac Echocardiogram, evaluating the valves, heart muscle, and major vessels (Aorta and Pulmonary arteries).
• Cardiac stress test to screen for unrecognized coronary artery diseases, hypertension, and abnormal heart rhythm, as well as to evaluate how your heart responds to physical activity.
• Ultra-fast CT scan Revolution Apex for evaluation of coronary heart disease.
Carotid Ultrasound
Screening of the carotid arteries of the neck for atherosclerosis and risk of stroke.
Pulmonary Function Tests (PFT )
To evaluate how well your lungs work. The tests can diagnose lung diseases and measure the severity of lung problems.
Colonoscopy
A fiber-optic evaluation of the entire colon to identify if there are polyps, cancer or other abnormalities.
A new diagnostic technique that uses computed tomography to help identify potential problems and diseases before symptoms even appear. The scan examines six major areas of the body: the heart and major blood vessels. Lungs, abdomen, pelvis and brain. The scan includes:
• Bone densitometry (dexa scan): For both men and women to determine the presence of bone loss (osteoporosis/osteopenia).
• Nutritional counseling: Taking into
account your overall assessment, medical history and personal goals, the dietician provides nutritional counseling, answers and questions about sports, nutrition and dietary supplements; also provides guidelines for healthy eating when dining out and traveling.
• Eye exam: A vision screening test and check for increased eye pressure that could lead to glaucoma, and an evaluation for cataracts.
• Audiogram: To evaluate your hearing and provide recommendations as needed for hearing amplification and preservation. For example, screening for HbA1c (glycated hemoglobin) can reveal diabetes or prediabetes before symptoms occur. Lipid profile tests similarly identify harmful cholesterol levels long before arterial damage begins. This early insight enables timely intervention and effective prevention.
The core strength of the program lies in its ability to detect health risks at their earliest stages, significantly boosting the chances of successful treatment and helping individuals maintain long-term health and well-being.
Our program offers tailored healthcare solutions that take into account each individual’s age, gender, medical history, and presenting symptoms. This personalized approach ensures that every aspect of the patient’s health is carefully considered, allowing for a highly targeted and effective evaluation.
Patients will enjoy premium accommodations, being admitted to a first-class room designed for comfort and privacy. Throughout their stay, they will be continuously accompanied by an executive nurse, ensuring attentive care and
www.cmc.com.lb www.cmc.com.lb www.cmc.com.lb
PREMIER EXECUTIVE HEALTH CHECK WAS ESTABLISHED MORE THAN 20 YEARS AGO AND HAS SINCE EVOLVED TO BECOME AN INTEGRAL PART OF THE CENTER'S SERVICES. THIS EXAMINATION IS OF PARAMOUNT IMPORTANCE NOT ONLY TO THE PATIENT BUT ALSO TO THEIR SURROUNDINGS. IT ENCOURAGES THE EARLY DETECTION OF ANY SILENT DISEASES THAT MAY NEGATIVELY AFFECT THE PATIENT'S LIFE. THIS EARLY DETECTION PLAYS A VITAL ROLE IN MAINTAINING AN INDIVIDUAL'S HEALTH AND ENABLING THEM TO LIVE A NORMAL AND PRODUCTIVE LIFE.
assistance at all times. A dedicated physician will oversee the patient’s case from start to finish, providing expert supervision. Upon completion of the program, patients will receive a comprehensive summary report detailing all findings, along with clear recommendations from the attending physician to guide their ongoing health management.
How does this program differ from routine checkups?
Clemenceau Medical Center’s Premier Executive Health Check surpasses traditional routine evaluations in scope and depth. Whereas standard checkups typically target a single organ system or focus, such as basic blood tests or a general physical exam, the comprehensive program adopts a multisystem, integrated diagnostic approach.
Key advanced components include:
• Echocardiography (cardiac ultrasound) to assess myocardial function and valvular integrity.
• Exercise stress testing (treadmill ECG) to evaluate myocardial perfusion and detect potential coronary artery stenosis or occlusion.
• Pulmonary function stress testing (spirometry/VO₂ max) is aimed at diagnosing respiratory disorders, especially in smokers.
• Computed Tomography (CT) scanning for early detection of thoracic and abdominal lesions, granulomatous conditions (e.g., tuberculosis), neoplasms, or other structural abnormalities.
While routine exams remain essential and are strongly encouraged, this comprehensive medical screening program offers far greater diagnostic breadth, enabling the proactive detection of health issues at earlier stages and facilitating more effective preventative measures for long-term well-being.
How does this program contribute to raising health awareness in the community?
Established more than 20 years ago, this health
program has a long-standing tradition of excellence and continuous improvement. It is regularly reviewed and updated to incorporate the latest medical advancements and best practices, ensuring that patients benefit from state-of-the-art preventive care and diagnostic services. It encourages the early detection of any silent diseases that may negatively affect the patient's life. This early detection plays a vital role in maintaining an individual's health and enabling them to live a normal and productive life.
Moreover, the impact of Premier Executive Health Check is not limited to individual health; it extends to promoting community health awareness as a whole. By providing these comprehensive examinations, the center contributes to spreading a culture of prevention and highlighting the importance of early detection of silent diseases, which may not show symptoms until advanced stages.
This, in turn, encourages individuals to take greater responsibility for their health, reduces misconceptions about illness, and prompts them to adopt better health behaviors and preventive lifestyles. Consequently, the proliferation of such programs contributes to building a healthier and more aware society, where the focus is on maintaining wellness before reaching the stage of complex and costly treatment.
What are the most prominent silent diseases this program focuses on? And why is early detection important before symptoms appear?
Specifically, the comprehensive screening program focuses on two vital aspects, in addition to other silent diseases.
First, we pay special attention to diabetes screening due to its significant impact on the body's arteries and nerves, including the coronary arteries. It increases the risk of blood clots and atherosclerosis, in addition to its potential effects on nerves in the feet and the body as a whole.
Second, the examinations aim to evaluate tumor markers. These tests give us an initial idea of whether a patient is susceptible to developing any type of malignant tumor or if there is any anomaly that could lead to tumor formation.
THE PROGRAM INCLUDES A WIDE RANGE OF PRECISE TESTS DESIGNED FOR THE EARLY DETECTION OF HEALTH PROBLEMS. THIS ENCOMPASSES COMPREHENSIVE BLOOD TESTS TO ASSESS KIDNEY AND LIVER FUNCTION, CHOLESTEROL LEVELS, THYROID FUNCTION, AND TUMOR MARKERS. A URINE TEST IS ALSO CONDUCTED TO DETECT PROTEIN EXCRETION THAT MAY INDICATE THE HEALTH AND FUNCTION OF THE RENAL ARTERIES.
This focus allows us to intervene early and take the necessary preventive measures.
This program is available to everyone, but we especially recommend it for businessmen and women who are short on time and find it difficult to visit multiple doctors at different appointments. The program typically starts at 9
instructions regarding dosage and timing. This ensures these silent diseases are treated effectively before any symptoms appear, achieving the highest degree of prevention.
You can book an appointment through the hospital's International Office one to two
www.cmc.com.lb www.cmc.com.lb www.cmc.com.lb
THE PROGRAM HIGHLIGHTS ITS EFFECTIVENESS IN THE EARLY DETECTION OF SILENT DISEASES, ESPECIALLY DIABETES, HIGH CHOLESTEROL, AND TUMORS. THE GOAL ISN'T JUST DETECTION; IT ALSO EXTENDS TO ENCOURAGING PATIENTS TO ADHERE CORRECTLY TO THEIR MEDICATION. GIVEN THE VAST AMOUNT OF INFORMATION AVAILABLE ONLINE AND THROUGH SOCIAL MEDIA TODAY, PATIENTS MAY QUESTION THE SIDE EFFECTS OF MEDICATIONS. THEREFORE, WE EMPHASIZE THE IMPORTANCE OF STRICTLY FOLLOWING THE DOCTOR'S INSTRUCTIONS REGARDING DOSAGE AND TIMING. THIS ENSURES THESE SILENT DISEASES ARE TREATED EFFECTIVELY BEFORE ANY SYMPTOMS APPEAR, ACHIEVING THE HIGHEST DEGREE OF PREVENTION.
approach
potential
Head and neck cancers that are not associated with human papillomavirus (HPV) infection can be treated with a novel treatment strategy including neoadjuvant chemotherapy and immunotherapy with encouraging results, according to a new study
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). More than half of study participants had 50% or more of their tumors shrink after receiving the immunotherapy drug nivolumab with chemotherapy, followed by response-adaptive chemo-radiation therapy.
The results of the Phase 2, nonrandomized clinical trial were published on March 6, 2025 in JAMA Oncology.
HPV-negative HNSCC is often diagnosed in older patients with a history of heavy smoking and alcohol use. These patients typically experience a poor quality of life and have the worst treatment outcomes among head and neck cancer patients. When the tumors are small in
IMMUNOTHERAPY COMBINED WITH CHEMOTHERAPY SHOWED PROMISING RESULTS IN TREATING ADVANCED HPVNEGATIVE HEAD AND NECK CANCER.
the early stages (Stage 1 or 2), they can be cured with surgery or radiation.
However, many cases are diagnosed at advanced stages (Stage 3 or 4) due to a lack of notable symptoms, which in turn makes treatment more challenging and contributes to high mortality rates.
The current standard of treatment, including chemo-radiation therapy or surgery, offers limited survival benefit for advanced, non-metastatic, HPV-negative HNSCC. Moreover, these treatments negatively impact speech, swallowing, and overall quality of life. There are two major unmet needs in this patient population: improving survival/ recurrence rates and optimizing treatments to minimize long-term side effects.
“Immunotherapy, specifically immune checkpoint inhibitors, has revolutionized the way we treat recurrent or metastatic head and neck cancers, improving survival outcomes. However, they have not played a significant role in curative intent thus far,” said Ari Rosenberg, MD, Assistant Professor of Medicine at UChicago Medicine and the corresponding author of the study.
Neoadjuvant therapy involves administering treatment prior to any surgery or radiation to shrink tumors. In this study of 36 patients with advanced HPV-negative HNSCC, researchers tested a regimen of three cycles of neoadjuvant chemotherapy combined with an immunotherapy drug, nivolumab, followed by chemo-radiation therapy. The group of patients who experienced more than 50% tumor shrinkage were assigned to the trial’s de-escalation arm, while the other arm received standard chemo-radiation therapy.
The main goal of the clinical trial was to evaluate the deep response rate, defined as the proportion of patients who achieved 50% or greater tumor shrinkage with neoadjuvant chemo-immunotherapy. The findings were
encouraging: 53% of patients achieved a deep response with neoadjuvant chemoimmunotherapy. “This result exceeded our expectations over our historical data with chemotherapy alone,” said Rosenberg.
Deeper responses were observed in patients with higher expression of programmed death-ligand 1 (PD-L1) suggesting that PD-L1 expression could serve as a potential biomarker to predict treatment response and a potential survival benefit for PD-L1-positive patients.
The study also assessed survival outcomes, treatment toxicities, patient function and quality of life. In this high-risk population with locally advanced Stage 4 head and neck cancer, the chemo-immunotherapy treatment approach led to impressive survival outcomes and fewer toxic side effects, especially among patients who responded favorably to neoadjuvant chemo-immunotherapy and received de-escalated treatment.
“This is the first study, to our knowledge, that evaluates neoadjuvant chemoimmunotherapy followed by response-adaptive de-escalation treatment in non-surgical HPVnegative HNSCC patients,” said Rosenberg. “These promising results pave the way for new treatment paradigms that not only improve survival but also enhance the quality of life for these patients.”
The study “Neoadjuvant nivolumab plus chemotherapy followed by response-stratified chemoradiation therapy in HPV-negative head and neck cancer: The DEPEND Phase 2 nonrandomized clinical trial,” was supported by a UChicago investigator-initiated clinical trial funded by Bristol Myers Squibb and Celgene, the University of Chicago Medicine Comprehensive Cancer Center Support Grant (NIH/NCI P30 CA014599), and the UChicago Medicine Head and Neck Cancer Program.
Additional authors included Evgeny Izumchenko, Jeffrey Chin, Alexander Pearson, Everett Vokes, Aditya Juloori, Nishant Agrawal, Nicole Cipriani, Mark Lingen, Rohan Katipally, Daniel Ginat, Olga Pasternak-Wise, Zhen Gooi, Elizabeth Blair, Daniel Haraf and John Cursio from the University of Chicago and Michael Jelinek from Rush University Chicago.
Ari Rosenberg, MD
Assistant Professor of Medicine (Hematology and Oncology)
Ari Rosenberg, MD, is an oncologist who specializes in using basic, translation and clinical research to improve the lives of his patients. As a clinical investigator, Dr. Rosenberg focuses on developing novel therapeutic strategies, including immunotherapy, for patients with head and neck cancer and thyroid cancer.
Ahistoric surgery, the result of years of research, opens the door for improved treatment of non-functioning bladders. A UCLA Health surgical team has performed the first-in-human bladder transplant, marking a major advancement in organ transplantation.
The procedure was successfully completed at Ronald Reagan UCLA Medical Center on May 4, 2025. The team was led by Dr. Nima Nassiri, a Urologic Transplant Surgeon and Director of the UCLA Vascularized Composite Bladder Allograft Transplant Program, with assistance from Dr. Inderbir Gill, founding executive director of USC Urology.
“Bladder transplantation has been Dr. Nassiri's principal academic focus since we recruited him to the UCLA faculty several
years ago,” said Dr. Mark Litwin, Chair of UCLA Urology. “It is incredibly gratifying to see him take this work from the laboratory to human patients at UCLA, which operates the busiest and most successful solid-organ transplant program in the western United States.”
“This first attempt at bladder transplantation has been over four years in the making,” Dr. Nima Nassiri said. “For the appropriately selected patient, it is exciting to be able to offer a new potential option.”
The patient had lost most of his bladder during a tumor removal, leaving the remainder too small and compromised to work. Both of his kidneys were subsequently removed due to renal cancer in the setting of pre-existing end-stage kidney disease. As a result, he was
AT UCLA, THE BLADDER AND KIDNEY TRANSPLANTATION PROGRAMS ARE BOTH HOUSED WITHIN THE DEPARTMENT OF UROLOGY, PROVIDING A UNIFIED SYSTEM FOR EVALUATION, SURGERY AND FOLLOW-UP CARE.
on dialysis for seven years. The biggest risks of organ transplantation are the body’s potential rejection of the organ and side effects caused by the mandatory immune suppressing drugs given to prevent organ rejection.
“Because of the need for long-term immunosuppression, the best current candidates are those who are already either on immunosuppression or have an imminent need for it,” Dr. Nassiri said.
Dr. Nassiri, previously a resident at the Keck School of Medicine of USC, and now a UCLA Health assistant professor of urology and kidney transplantation, worked with Dr. Gill to develop the surgical technique, design trials, and secure approvals.
They collaborated for years to prepare for this milestone. Many pre-clinical procedures were conducted at USC and OneLegacy, Southern California’s organ procurement organization.
The donor bladder and kidney were recovered at OneLegacy. All parts of the procedure, including recovery, surgery, and monitoring, followed rigorous clinical and research standards. During the surgery, the team first transplanted the donated kidney, followed by the bladder. They used a technique they developed to connect the new kidney to the new bladder. The surgery lasted approximately eight hours.
“The kidney immediately made a large volume of urine, and the patient’s kidney function improved immediately,” Dr. Nassiri said. “There was no need for any dialysis after surgery, and the urine drained properly into the new bladder.”
Millions worldwide suffer from bladder dysfunction, with some experiencing terminal bladders that no longer function or cause ongoing complications like pain and infections. In severe cases, or after bladder removal, treatment options include using part of the patient’s intestine to form a urinary reservoir.
While these surgeries can be effective, they
come with many short- and long-term risks that compromise a patient’s health such as internal bleeding, bacterial infection and digestive issues.
“A bladder transplant, by contrast, creates a more natural urinary reservoir and may avoid some of the risks tied to using the intestine,” said Dr. Nassiri.
As the first of its kind, the procedure carries unknowns, such as how the transplanted bladder will function over time and the extent of immunosuppression needed.
Bladder transplantation hasn’t been attempted before, partly due to the complex vascular structure of the pelvis and the technical difficulty. To prepare, Dr. Nassiri and Dr. Gill performed multiple practice surgeries at Keck Medical Center, including the first-ever robotic bladder retrievals and successful robotic bladder transplants in five recently deceased donors whose cardiac function was maintained via ventilator. They also conducted non-robotic trial runs at OneLegacy, collaborating with multidisciplinary teams to refine the technique.
At UCLA, the bladder and kidney transplantation programs are both housed within the Department of Urology, providing a unified system for evaluation, surgery and follow-up care.
This made UCLA uniquely equipped to perform the combined transplant, with the infrastructure, expertise, and support to manage the procedure and patient recovery from start to finish within one department.
The transplant was performed as part of a UCLA clinical trial, and Dr. Nassiri hopes to offer this procedure to more patients in the future.
UCLA Urology has long been a pioneer in transplantation, leading groundbreaking research in kidney transplantation and now, bladder transplantation.
For more information, please visit https://www.uclahealth.org/international-services/ or call +1 310-794-8759
THE PROCEDURE WAS SUCCESSFULLY COMPLETED AT RONALD REAGAN UCLA MEDICAL CENTER ON MAY 4, 2025. THE TEAM WAS LED BY DR. NIMA NASSIRI, A UROLOGIC TRANSPLANT SURGEON AND DIRECTOR OF THE UCLA VASCULARIZED COMPOSITE BLADDER ALLOGRAFT TRANSPLANT PROGRAM, WITH ASSISTANCE FROM DR. INDERBIR GILL, FOUNDING EXECUTIVE DIRECTOR OF USC UROLOGY.
First
Asurgeon at Baylor St. Luke's Medical Center successfully performed a fully robotic heart transplant on an adult patient – the first reported in the United States.
Using a surgical robot, lead surgeon Dr. Kenneth Liao and his team made small, precise incisions, eliminating the need to open the chest and break the breast bone. Liao removed the diseased heart, and the new heart was implanted through preperitoneal space, avoiding chest incision.
"Opening the chest and spreading the breastbone can affect wound healing and
delay rehabilitation and prolong the patient's recovery, especially in heart transplant patients who take immunosuppressants," said Dr. Kenneth Liao, Professor and Chief of Cardiothoracic Transplantation and Circulatory Support at Baylor College of Medicine and chief of cardiothoracic transplantation and mechanical circulatory support at Baylor St. Luke’s Medical Center. "With the robotic approach, we preserve the integrity of the chest wall, which reduces the risk of infection and helps with early mobility, respiratory function and overall recovery."
USING A SURGICAL ROBOT, LEAD SURGEON DR. KENNETH LIAO AND HIS TEAM MADE SMALL, PRECISE INCISIONS, ELIMINATING THE NEED TO OPEN THE CHEST AND BREAK THE BREAST BONE.
In addition to less surgical trauma, the clinical benefits of robotic heart transplant surgery include avoiding excessive bleeding from cutting the bone and reducing the need for blood transfusions, which minimizes the risk of developing antibodies against the transplanted heart. Before the transplant surgery, the 45-year-old patient had been hospitalized with advanced heart failure since November 2024 and required multiple mechanical devices to support his heart function. He received a heart transplant in early March 2025 and after heart transplant surgery, he spent a month in the hospital before being discharged home, without complications.
“Becoming the home of this medical breakthrough in robotic heart transplantation further establishes Baylor St. Luke’s Medical Center as a worldwide health care leader,” said Dr. Bradley T. Lembcke, Hospital President. “This pinnacle in heart transplantation brings great pride to our hospital and adds to its legacy of medical
achievements and caring for the most complex health conditions that only advanced health care systems can treat successfully.”
"This transplant shows what is possible when innovation and surgical experience come together to improve patient care. Our goal is to offer patients the safest, most effective and least invasive procedures, and robotic technology allows us to do that in extraordinary ways," said Liao.
"This robotic heart transplantation represents a remarkable, giant step forward in making even the most complex surgery safer and we are delighted to offer this great success to the world," said Dr. Todd Rosengart, Chair of the Michael E. DeBakey Department of Surgery at Baylor.
IN ADDITION TO LESS SURGICAL TRAUMA, THE CLINICAL BENEFITS OF ROBOTIC HEART TRANSPLANT SURGERY INCLUDE AVOIDING EXCESSIVE BLEEDING FROM CUTTING THE BONE AND REDUCING THE NEED FOR BLOOD TRANSFUSIONS, WHICH MINIMIZES THE RISK OF DEVELOPING ANTIBODIES AGAINST THE TRANSPLANTED HEART.
Climate change affects human health through both direct and indirect pathways. Directly, it increases mortality and injury from extreme weather events such as heatwaves, wildfires, floods, and storms. Indirectly, it alters ecosystems, worsens air quality, disrupts food and water security, and facilitates the spread of infectious diseases. Vulnerable groups, including the elderly, children, low-income communities, and individuals with chronic illnesses, are at the greatest risk.
One of the most significant threats is the spread of vector-borne diseases into new geographic areas. Rising temperatures and shifting rainfall patterns expand suitable habitats for vectors such as mosquitoes, allowing them to establish and thrive in regions that were
previously unsuitable. Consequently, diseases like malaria, dengue fever, West Nile virus, and Lyme disease may appear in areas that were once protected by cooler climates.
Climate change also affects water safety. Waterborne diseases increase as water sources become contaminated. Intense flooding heightens the risk of freshwater pollution, leading to outbreaks of diseases such as cholera and typhoid. After flooding, sewage may mix with drinking water supplies, rendering them unsafe. Prolonged droughts can also degrade water quality by concentrating pollutants and pathogens in limited supplies.
Food security is equally affected. Changes in temperature and rainfall patterns disrupt crop yields and livestock production, threatening global food systems. Malnutrition
VULNERABLE GROUPS, INCLUDING THE ELDERLY, CHILDREN, LOW-INCOME COMMUNITIES, AND INDIVIDUALS WITH CHRONIC ILLNESSES, ARE AT THE GREATEST RISK.
and undernourishment weaken the immune system, increasing susceptibility to infectious diseases, including foodborne illnesses resulting from spoiled produce or improper food storage under extreme climate conditions. Rising temperatures and wildfires elevate air pollutants such as fine particulate matter and ozone. These pollutants contribute to serious respiratory conditions. Individuals with asthma or pneumonia are especially vulnerable and may experience worsened symptoms or increased risk of infections caused by airborne bacteria and viruses.
As global temperatures rise, cases of heat exhaustion and heatstroke are becoming more frequent. The body struggles to cool itself, leading to dangerously high internal temperatures that can damage vital organs and, in severe cases, result in death.
Increased sweating during heat events raises the risk of dehydration if fluids are not adequately replenished. Dehydration can impair kidney function, circulation, and neurological performance.
High temperatures place additional strain on the heart and blood vessels. The cardiovascular system must work harder to pump blood to the skin’s surface for cooling. This raises the risk of heart attacks and strokes, particularly among older adults and individuals with pre-existing heart conditions.
Extreme heat can worsen chronic diseases such as respiratory conditions (asthma, chronic obstructive pulmonary disease), kidney disease, and diabetes. Hospital admissions and mortality rates increase significantly during heatwaves among affected populations.
High temperatures, altered rainfall patterns, and increased humidity create ideal conditions for the proliferation of vectors such as mosquitoes and ticks.
Warmer temperatures accelerate mosquito development, increase their reproduction rate, and shorten the incubation period of the pathogens they carry. Diseases like dengue fever and malaria are highly sensitive to these climatic shifts. Regions once too cold for mosquito populations are now becoming suitable habitats. For example, dengue has been reported in parts of southern Europe, and malaria is reappearing in some African highlands. Increased rainfall also creates more stagnant water bodies, ideal breeding grounds for mosquitoes.
Warmer winters and prolonged warm seasons contribute to the spread of tick populations into higher latitudes and elevations. This raises the incidence of diseases such as Lyme disease and tick-borne encephalitis, exposing new populations to these health threats. Ticks remain active for longer periods, increasing the likelihood of human transmission.
Changes in rainfall patterns, including extreme flooding and prolonged drought, directly affect water quality and the transmission of waterborne pathogens.
Heavy rainfall and flooding can overwhelm sewage systems, contaminating freshwater sources with untreated sewage, agricultural runoff, and other pollutants. This creates an environment conducive to the rapid spread of bacteria and viruses that cause diseases like cholera, typhoid fever, salmonella infections, and giardiasis. Communities with inadequate water, sanitation, and hygiene infrastructure are particularly at risk during and after flood events.
EXTREME WEATHER EVENTS SUCH AS FLOODS AND WILDFIRES CAN LEAD TO ANXIETY, DEPRESSION, AND GRIEF AMONG SURVIVORS WHO EXPERIENCE THE LOSS OF LOVED ONES, HOMES, OR LIVELIHOODS. STUDIES INDICATE THAT 30 TO 40 PERCENT OF DIRECTLY AFFECTED INDIVIDUALS MAY DEVELOP POSTTRAUMATIC STRESS DISORDER (PTSD), WITH SYMPTOMS INCLUDING FLASHBACKS, NIGHTMARES, AND PROLONGED ANXIETY.
Higher temperatures in rivers, lakes, and coastal zones enhance the survival and reproduction of many waterborne pathogens, including Vibrio cholerae and various salmonella strains. Warmer oceans also increase the risk of Vibrio infections from seafood consumption or exposure of open wounds to contaminated seawater.
Paradoxically, prolonged droughts also increase waterborne disease risks. Scarcity of safe water may force populations to rely on unsafe or untreated sources. Shrinking water bodies lead to higher concentrations of pathogens in the remaining water, making limited supplies more dangerous. Cholera outbreaks have occurred in regions affected by severe droughts.
Climate change poses an existential threat to global food and nutrition security by destabilizing agricultural systems and compromising the ability to produce and distribute adequate and nutritious food, particularly in vulnerable countries.
Declining crop yields decrease food supply locally and nationally, raising prices that mainly impact low-income groups.
When food becomes scarce or unaffordable, individuals reduce their intake, leading to calorie deficiency and acute malnutrition, particularly among children, pregnant women, the elderly, and those with existing health conditions. Climate change reduces the nutrient quality of crops like rice and wheat, leading to fewer nutrients and greater risk of deficiencies.
Developing nations, particularly those reliant on agriculture for food and income, face the greatest risks. Limited adaptation capacity, financial resources, and infrastructure make these countries more vulnerable to humanitarian crises and rising hunger levels.
Climate change affects not only physical health but also mental well-being. Psychological effects arise from both acute and chronic climaterelated stressors.
Extreme weather events such as floods and wildfires can lead to anxiety, depression, and grief among survivors who experience the loss of loved ones, homes, or livelihoods. Studies indicate that 30 to 40 percent of directly affected individuals may develop post-traumatic stress disorder (PTSD), with symptoms including flashbacks, nightmares, and prolonged anxiety.
Beyond acute trauma, climate change also contributes to eco-grief, a deep sense of sadness and helplessness stemming from the degradation or loss of ecosystems and species. Individuals witnessing these changes in their environments may experience a profound emotional toll.
Addressing the health impacts of climate change requires a dual approach. On one hand, mitigation strategies such as transitioning to clean energy, improving energy efficiency, adopting sustainable transportation and agriculture, and implementing waste management systems are essential for reducing emissions and improving air quality.
On the other hand, adaptation is equally important. Strengthening health systems with early warning mechanisms, training personnel, adapting infrastructure, and improving water and sanitation management are key to ensuring safe water access. Enhancing food security through climate-resilient crops and sustainable farming practices is vital.
Equally important is integrating mental health support into disaster response systems to manage anxiety, depression, and PTSD.
Tackling vector-borne and waterborne diseases through surveillance and control measures is crucial.
Finally, incorporating health into all climate policies and fostering multi-sectoral collaboration are essential for an effective and comprehensive response.
WARMER TEMPERATURES ACCELERATE MOSQUITO DEVELOPMENT, INCREASE THEIR REPRODUCTION RATE, AND SHORTEN THE INCUBATION PERIOD OF THE PATHOGENS THEY CARRY. DISEASES LIKE DENGUE FEVER AND MALARIA ARE HIGHLY SENSITIVE TO THESE CLIMATIC SHIFTS. REGIONS ONCE TOO COLD FOR MOSQUITO POPULATIONS ARE NOW BECOMING SUITABLE HABITATS. FOR EXAMPLE, DENGUE HAS BEEN REPORTED IN PARTS OF SOUTHERN EUROPE, AND MALARIA IS REAPPEARING IN SOME AFRICAN HIGHLANDS.
Dr. Mohammad Issa Dauleh, Consultant Urologist and Head of
Department at Al-Ahli Hospital/Qatar
For years, men have learned to live with discomfort, to stay silent through the night-time trips to the bathroom, the slow urine stream, the social hesitations, and the quiet worry that something just isn’t right.
The cause? Benign Prostatic enlargement (BPE), a non-cancerous enlargement of the prostate that affects more than 50% of men over the age of 60, and nearly 80% over 70.
At Al-Ahli Hospital, we believe it’s time to talk about it. Not just talk, but act boldly and gently, with the latest innovation in urology care: Steam Therapy.
For many men, BPE doesn't arrive with drama. It comes quietly, first with waking up at night to urinate, then with hesitating at public events, then the frustration of never truly emptying the bladder. Left untreated, it can lead to urinary retention, bladder infections, or worse, invasive surgery. While traditional solutions like medications or transurethral resection surgery (TUR-P) work, they often come at the cost of side effects, sometimes impacting sexual health, requiring hospitalization, and carrying emotional tolls. At Al-Ahli Hospital, we are proud to offer Water Vapor Therapy, a game-changing procedure that uses the
ENLARGED PROSTATE MAY BE COMMON BUT SUFFERING FROM IT DOESN’T HAVE TO BE. WITH STEAM THERAPY AT AL-AHLI, MEN FINALLY HAVE A TREATMENT THAT ALIGNS WITH THE VALUES THEY HOLD DEAR: DISCRETION, DIGNITY, AND DECISIVENESS.
natural power of steam to shrink prostate tissue, improve urine flow, and eliminate symptoms, all without cutting, stitches, or long recovery.
Here’s how it works
• A small device is inserted through the urethra under anesthesia.
• Steam at 103°C is released in short pulses directly into the enlarged parts of the prostate.
• The steam causes the problematic tissue to die off and shrink.
• In just 10–15 minutes, the urethra is relieved, and normal urinary flow is gradually restored.
This therapy FDA-approved introduced in the United States in 2015, United Kingdom National Institute of clinical excellence (NICE) approved it in 2018, supported by years of clinical success, giving men the choice to reclaim their quality of life.
Steam at Al-Ahli ? What makes Al-Ahli’s steam therapy experience different?
• Expertise and empathy: Our team of world-class urologists combines technical excellence with a deeply human approach.
• No overnight stay. No scalpels. A simple outpatient procedure.
• Preserves sexual health: Unlike many surgeries, steam therapy rarely interferes with erectile function or ejaculation.
• Fast recovery: Most men return to work within a few days.
• Confidence, restored: More than just symptom relief, patients gain back control, comfort, and dignity.
I never thought something so simple could change so much,” shares one of our patients. “No more pills, no more fear I got my life back.”
Steam therapy is ideal for:
• Men aged 50+
• Experiencing moderate to severe urinary symptoms
• Those who don’t respond well to medication
• Men at high surgical risk or with other health conditions
• Anyone seeking a long-term solution without side effects
Like any procedure, minor short-term effects may include burning during urination, slight bleeding, or temporary difficulty urinating. These usually subside within 4–6 weeks. Most patients begin noticing improvement within 2 weeks, and full benefits appear within 3 months.
Al-Ahli Hospital doesn’t follow trends we set standards. Steam therapy is just one example of how we integrate technology, trust, and tradition to serve our patients with excellence. Our commitment to men’s health extends beyond treatments into conversation, awareness, and community trust.
We encourage every man to listen to his body and choose a path that’s modern, safe, and centered around him.
Enlarged prostate may be common but suffering from it doesn’t have to be. With Steam Therapy at Al-Ahli, men finally have a treatment that aligns with the values they hold dear: discretion, dignity, and decisiveness.
This is more than urology it’s about restoring everyday life, one drop of steam at a time. Book your consultation today. At Al-Ahli Hospital, your health is in expert, caring hands.
www.ahlihospital.com
FOR MANY MEN, BPE DOESN'T ARRIVE WITH DRAMA. IT COMES QUIETLY, FIRST WITH WAKING UP AT NIGHT TO URINATE, THEN WITH HESITATING AT PUBLIC EVENTS, THEN THE FRUSTRATION OF NEVER TRULY EMPTYING THE BLADDER. LEFT UNTREATED, IT CAN LEAD TO URINARY RETENTION, BLADDER INFECTIONS, OR WORSE, INVASIVE SURGERY. WHILE TRADITIONAL SOLUTIONS LIKE MEDICATIONS OR TRANSURETHRAL RESECTION SURGERY (TUR-P) WORK, THEY OFTEN COME AT THE COST OF SIDE EFFECTS, SOMETIMES IMPACTING SEXUAL HEALTH, REQUIRING HOSPITALIZATION, AND CARRYING EMOTIONAL TOLLS.
Fulfill your dream of becoming parents with the help of an individualized treatment approach, an experienced team, and advanced technologies at Acıbadem IVF Center.
Assisted reproductive technologies have been helping couples fulfill their dreams of parenthood for years. Every year, the number of couples seeking this treatment increases. Why? Factors such as the rising age of marriage and delayed decisions to have children play a significant role. As a natural result, the chances of conceiving naturally decrease, making IVF treatments the best option for many couples to achieve pregnancy.
Fortunately, advances in assisted reproductive technologies continue to meet the expectations of couples. How? Like other fields of medicine, this area has witnessed
remarkable progress. Pre-implantation genetic testing helps prevent implantation failure and miscarriage, while innovative approaches focus on improving the ovarian reserve in women. Moreover, advancements have made it possible to enhance sperm concentration and motility, improving the chances of conception in cases of male factor infertility. In summary, assisted reproductive technologies can now help more than ever to address the desire of couples to have babies.
In the field of reproductive medicine and fertility, significant advancements such as laboratory techniques, technology, medications, surgical methods, and the development of
THE EXPERIENCE OF PHYSICIANS, EMBRYOLOGISTS, AND NURSES IS ONE OF THE MOST SIGNIFICANT FACTORS IN ACHIEVING HIGHER SUCCESS RATES IN IVF TREATMENT.
specialized equipment have had a major impact on overall IVF success rates. For example, egg collection and embryo transfer procedures are routinely performed under ultrasound guidance. Ongoing advancements in ultrasound resolution and quality have made these procedures safer and more precise. Another example is pre-implantation genetic testing (PGT), which assesses embryos in the laboratory before transfer to the uterus. It helps identify genetic issues that could lead to implantation failure, miscarriage, or birth defects, enabling the selection of genetically healthy embryos and improving the likelihood of conception.
PRP is a promising method for addressing both female and male factor infertility. By stimulating the ovaries, it may enhance egg quality and quantity, potentially increasing the chances of pregnancy. Head of Acıbadem Maslak Hospital IVF Clinic Professor Bülent Tıraş marks that this procedure has been performed since 2016 and it offers auspicious results. For women who received PRP injections, when ovarian reserve parameters were analyzed, it was observed a statistically significant increase in AFC and AMH, decrease in serum FSH, which are indicative of favorable responses; "In one of our studies, we conducted a comprehensive study involving 510 women experiencing poor ovarian response with an average age of 40.3. Following the PRP and IVF procedures, we achieved a 20% pregnancy rate. These findings highlight the potential benefits of PRP in enhancing fertility treatments, especially for women facing specific challenges in conception.”
Additionally, PRP can be used for treating male infertility, particularly for men with non-obstructive azoospermia. To investigate the effects and benefits of PRP on male infertility caused by azoospermia, published the first academic study in this field, achieving promising outcomes. Testicular PRP therapy was administered to 135 men included in the study, resulting in positive sperm retrieval rates of 27.5% in patients with one prior failed Micro-
TESE procedure and 16.4% in those with two or more failed attempts.
The experience of physicians, embryologists, and nurses is one of the most significant factors in achieving higher success rates in IVF treatment. This is why a couple who has experienced failed IVF attempts at one clinic may achieve positive results at another clinic. While technology is accessible to many clinics worldwide that can afford the costs, a medical team’s experience and dedication are qualities that are not easily found everywhere. It is crucial to identify the treatment modality that would be most beneficial for each patient, as the reasons for infertility can vary from case to case. Even when two patients share the same infertility cause, their treatment plans may differ. Individualized approaches are necessary for every patient.
At Acıbadem IVF Center, where approximately 10,000 IVF cycles are performed annually, fertility specialists with over 30 years of experience develop customized treatment plans based on each couple’s individual conditions and needs, significantly improving the chances of IVF success
AT ACIBADEM IVF CENTER, WHERE APPROXIMATELY 10,000 IVF CYCLES ARE PERFORMED ANNUALLY, FERTILITY SPECIALISTS WITH OVER 30 YEARS OF EXPERIENCE DEVELOP CUSTOMIZED TREATMENT PLANS BASED ON EACH COUPLE’S INDIVIDUAL CONDITIONS AND NEEDS, SIGNIFICANTLY IMPROVING THE CHANCES OF IVF SUCCESS.
The AURA 3D Imaging System represents a significant leap forward in skin analysis. It distinguishes itself from traditional 2D methods by capturing a true 3D digital replica of the face, chin, neck, and submental area. This advanced system utilizes multiple camera angles and synchronized flashes, ensuring consistent and clinically accurate scans regardless of external lighting or room conditions. This reliability is crucial for precise before-and-after comparisons and tracking changes over time. Mona Mirza, Founder & CEO at Biolite Aesthetic Clinic, during an interview with ‘Hospitals’ magazine, explains that AURA 3D imaging system empowers practitioners to design highly tailored and results-driven treatment plans.
What sets the AURA 3D Imaging System apart from traditional skin analysis methods?
At Biolite Clinic, we’ve always invested in technology that enhances precision, improves consumer trust, and delivers measurable results, and AURA does precisely that. Unlike older 2D systems, AURA captures a true 3D digital twin of the face, chin, neck, and submental area, using multiple camera angles and synchronized flashes that are unaffected by external lighting. It’s incredibly reliable. Each scan is consistent, regardless of the time of day or room conditions, which means that before-andafter comparisons are always clinically accurate. The intuitive interface makes it effortless for our team to use during consultations, while the quantifiable data helps us map changes over time. It provides our practitioners with clarity and our consumers with confidence, which is precisely what modern aesthetic care should deliver.
ONE OF THE MOST VALUABLE THINGS AURA BRINGS TO THE TABLE IS CLINICAL OBJECTIVITY. IT ENABLES OUR DOCTORS AND THERAPISTS TO SEE BEYOND WHAT’S VISIBLE TO THE NAKED EYE, OFFERING MEASURABLE DATA ON VOLUME LOSS, ASYMMETRY, TEXTURAL ISSUES, PIGMENTATION, AND MORE. THIS ENABLES US TO DESIGN TAILORED, RESULTSDRIVEN TREATMENT PLANS AND ADJUST THEM DYNAMICALLY BASED ON HOW THE SKIN RESPONDS.
How does the AURA 3D Imaging System enhance consumer care and treatment outcomes?
One of the most valuable things AURA brings to the table is clinical objectivity. It enables our doctors and therapists to see beyond what’s visible to the naked eye, offering measurable data on volume loss, asymmetry, textural issues, pigmentation, and more.
This enables us to design tailored, resultsdriven treatment plans and adjust them dynamically based on how the skin responds. Whether we’re tracking collagen stimulation after Sofwave or the volumetric balance following injectables, AURA gives us a clear roadmap. For consumers, it eliminates the guesswork from their journey, replacing it with trust, clarity, and a sense of control.
Can you describe the consumer experience during a typical AURA 3D Imaging System session?
It’s swift, clean, and non-invasive. The client aligns their eyes with a small on-screen guide, no chin rest, no harsh light, no discomfort. A series of brief, synchronized flashes captures multiple angles in one seamless scan.
From there, we walk the consumer through their 3D facial twin, highlighting key concerns and showing them precisely what we see, across zones like the forehead, cheeks, jawline, and neck. The entire experience feels elevated, professional, and deeply personalized, and often, consumers tell us they finally understand their skin on a whole new level.
In your opinion, how does the AURA 3D Imaging System contribute to the advancement of aesthetic medicine in the region?
AURA raises the standard for what aesthetic consultations should be, data-driven, transparent, and beautifully presented. In a region like ours, where clients are discerning and results-focused, this kind of clinical integrity is essential.
It empowers practitioners to move from opinion to evidence, and helps consumers feel
genuinely informed, not just convinced. At Biolite, it has completely redefined the way we assess, plan, and communicate outcomes. It bridges the gap between artistry and science in a way that truly elevates the aesthetic conversation.
What types of skin concerns can the AURA 3D Skin Analyzer detect and monitor?
AURA is incredibly comprehensive. It can accurately identify and track:
• Wrinkles and fine lines.
• Volume loss and asymmetry.
• Pigmentation and UV damage.
• Texture irregularities and enlarged pores.
• Redness and vascular activity.
• Dynamic facial movement (neutral, smile, surprise, kiss).
• Skin tone evenness.
• Oil, hydration, and overall skin health scoring.
The 3D data and AI scoring help us understand not just what’s visible now, but what’s forming beneath the surface, giving us a head start in preventative care.
How do you see the future of skin analysis evolving with technologies like AURA?
The future is moving toward intelligent, predictive, and hyper-personalized skincare, and AURA is already paving that path. As AI continues to evolve, we expect to see systems that can forecast aging trajectories, recommend personalized protocols, and integrate seamlessly with electronic medical records (EMRs) and wearable diagnostics.
At Biolite, where aesthetics meets regenerative wellness, this level of insight will be invaluable, allowing us to treat not just what we see, but what we anticipate. Technologies like AURA are transforming consultations from reactive conversations into proactive, empowered journeys, which is precisely where modern medicine is heading.
AT BIOLITE, WHERE AESTHETICS MEETS REGENERATIVE WELLNESS, THIS LEVEL OF INSIGHT WILL BE INVALUABLE, ALLOWING US TO TREAT NOT JUST WHAT WE SEE, BUT WHAT WE ANTICIPATE. TECHNOLOGIES LIKE AURA ARE TRANSFORMING CONSULTATIONS FROM REACTIVE CONVERSATIONS INTO PROACTIVE, EMPOWERED JOURNEYS, WHICH IS PRECISELY WHERE MODERN MEDICINE IS HEADING.
Cellulite is a common skin condition, particularly among women, and occurs when accumulated fat pushes against connective tissues beneath the skin, creating a dimpled or uneven appearance. While it poses no health risk, many women seek ways to reduce its visibility. Below is a comprehensive overview of the most prominent techniques and methods available today for minimizing the appearance of cellulite:
Topical creams remain a popular choice among women seeking to improve the appearance of cellulite. These products typically contain active ingredients aimed at tightening the skin, enhancing local blood circulation, or breaking down fat deposits directly, all of which can help reduce the visibility of cellulite.
However, it is important to note that these effects are often temporary. Most active ingredients in topical formulations do not penetrate deep enough into the skin layers to create lasting structural changes in fat or connective tissue. To maintain even minimal results, regular and consistent use is essential.
Treatments such as mechanical massage (e.g., Endermologie) are widely offered as options for addressing cellulite. These involve the use of motorized rollers in combination with suction technology to stimulate lymphatic drainage. This process helps reduce fluid retention and toxins in tissues, while also improving blood flow in targeted areas.
Though results are typically temporary, massage can enhance skin texture, making it appear smoother and less bumpy. Multiple sessions are usually required to achieve and sustain visible benefits.
Ultrasound technology is a modern, non-invasive
approach increasingly used in cosmetic and body contouring treatments. It utilizes high-frequency sound waves that penetrate the skin to induce specific biological and physical effects.
Ultrasound targets fat deposits by generating internal vibrations and localized heat, which break down fat cells. These are then naturally eliminated by the lymphatic system and liver. Simultaneously, the procedure stimulates collagen and elastin production, improving skin firmness and elasticity, and reducing the appearance of cellulite.
These techniques operate on the principle of heating targeted tissue beneath the skin’s surface. Laser and radiofrequency energy raise the temperature of fat cells in the deep dermal layers, causing fat cell shrinkage or breakdown. Some less-invasive systems liquefy fat deposits, making it easier for the body to eliminate them. Moreover, the thermal effect stimulates new collagen synthesis and remodeling of existing collagen fibers. As collagen contracts in response to heat, the skin tightens immediately. Over time, fibroblasts generate new collagen, improving skin elasticity and firmness while smoothing out dimples and irregularities caused by cellulite.
This technique uses high-frequency sound waves applied directly to problem areas to disrupt stubborn fat deposits beneath the skin. At the same time, it encourages collagen production in skin cells, boosting elasticity and improving the skin’s overall appearance.
Subcision is a minimally invasive procedure that targets moderate to severe cellulite. It involves using a specialized needle or blade to sever
TREATMENTS SUCH AS MECHANICAL MASSAGE (E.G., ENDERMOLOGIE) ARE WIDELY OFFERED AS OPTIONS FOR ADDRESSING CELLULITE. THESE INVOLVE THE USE OF MOTORIZED ROLLERS IN COMBINATION WITH SUCTION TECHNOLOGY TO STIMULATE LYMPHATIC DRAINAGE. THIS PROCESS HELPS REDUCE FLUID RETENTION AND TOXINS IN TISSUES, WHILE ALSO IMPROVING BLOOD FLOW IN TARGETED AREAS. THOUGH RESULTS ARE TYPICALLY TEMPORARY, MASSAGE CAN ENHANCE SKIN TEXTURE, MAKING IT APPEAR SMOOTHER AND LESS BUMPY. MULTIPLE SESSIONS ARE USUALLY REQUIRED TO ACHIEVE AND SUSTAIN VISIBLE BENEFITS.
the fibrous bands beneath the skin that pull it downward and create a puckered or dimpled surface.
By releasing these tight bands, the skin becomes smoother and more even. This method is especially effective when fibrous septae are visibly contributing to the skin's uneven texture.
Injectable treatments represent a significant advancement in the realm of non-surgical cellulite therapy, effectively addressing the underlying causes that lie beneath the skin’s surface. One of the most notable injectable options is the use of Collagenase Clostridium Histolyticum (CCH), which is a purified formulation derived from bacterial enzymes. These specialized enzymes are crafted to specifically target and break down types I and III collagen. These collagen types form the tight fibrous septae that pull the skin downward,
contributing to the formation of visible dimpling that many seek to eliminate.
When CCH is injected into the areas affected by cellulite, it initiates a process known as enzymatic disruption. This innovative process works by breaking apart the fibrous bands that tether the skin, effectively releasing tension and allowing the skin to become smoother and more level. With the recent advancements in injectable treatments, individuals who are struggling with the visible and often frustrating problem of cellulite now have a promising new option to consider. These innovative treatments can significantly enhance the appearance of their skin, helping to smooth out dimpled or uneven textures. Importantly, this approach offers a non-surgical alternative, making it an appealing choice for those seeking effective results with less risk, minimal downtime, and greater convenience compared to traditional surgical procedures.
INJECTABLE TREATMENTS REPRESENT A SIGNIFICANT ADVANCEMENT IN THE REALM OF NON-SURGICAL CELLULITE THERAPY, EFFECTIVELY ADDRESSING THE UNDERLYING CAUSES THAT LIE BENEATH THE SKIN’S SURFACE.
Dr. Fadi Hamadani, Plastic, Cosmetic, and Reconstructive Surgeon
As part of its ongoing commitment to showcasing the latest innovations in cosmetic surgery, “Hospitals” Magazine is delighted to feature Dr. Fadi Hamadani, a renowned Plastic, Cosmetic, and Reconstructive Surgeon. In this insightful interview, we'll dive deep into the groundbreaking BodyTite technology, exploring how this innovative solution has revolutionized body contouring and skin tightening, and delivers exceptional results with minimal surgical intervention.
What is BodyTite, and how does it differ from traditional liposuction or other body contouring procedures?
BodyTite is a minimally invasive body contouring solution that addresses fat reduction and skin tightening in a single procedure. Unlike traditional liposuction, which removes fat without addressing skin tone, BodyTite utilizes radiofrequency-assisted lipolysis (RFAL) to
target subcutaneous fat while heating the dermis and fibroseptal network.
This results in controlled fat coagulation and significant tissue contraction. The technology is particularly valuable for patients with mild to moderate skin laxity, who may not benefit fully from liposuction alone.
Because of its dual action, aspiration and RF-induced tightening, BodyTite offers more comprehensive contouring results with reduced risk of skin redundancy post-procedure. It also requires smaller incisions, is typically performed under local anesthesia, and provides faster recovery compared to surgical alternatives. This makes it a preferred option for patients seeking surgical-level outcomes without traditional methods' scarring or extended downtime.
What is the technology behind BodyTite, and how does it use radiofrequency energy to tighten skin and reduce fat?
BodyTite’s technology is based on bipolar radiofrequency-assisted lipolysis (RFAL). It uses a dual-probe system, one internal cannula inserted under the skin and one external electrode above, to deliver precise, focused RF energy. This energy heats the adipose tissue and fibrous septae, causing adipocyte disruption and fat liquefaction for easier aspiration. Simultaneously, thermal stimulation in the dermis promotes collagen denaturation and remodeling, improving skin firmness and elasticity. Real-time feedback mechanisms, including temperature and impedance monitoring, ensure safe and effective treatment, maintaining optimal internal temperatures (60–70°C) and external temperatures (38–42°C).
The thermal effect on the subdermal tissue network leads to skin contraction and tightening that continues for months post-procedure. This unique bipolar design distinguishes BodyTite from monopolar devices by allowing for greater
BODYTITE IS A MINIMALLY INVASIVE BODY CONTOURING SOLUTION THAT ADDRESSES FAT REDUCTION AND SKIN TIGHTENING IN A SINGLE PROCEDURE. UNLIKE TRADITIONAL LIPOSUCTION, WHICH REMOVES FAT WITHOUT ADDRESSING SKIN TONE, BODYTITE UTILIZES RADIOFREQUENCYASSISTED LIPOLYSIS (RFAL) TO TARGET SUBCUTANEOUS FAT WHILE HEATING THE DERMIS AND FIBROSEPTAL NETWORK.
precision and uniform heating. The result is a consistent fat reduction with significant skin tightening, making it particularly effective in areas prone to laxity.
BodyTite is suitable for many body areas where fat reduction and skin tightening are desired. Commonly treated regions include the abdomen, flanks, thighs, upper arms, bra rolls, back, and knees. It is also frequently used to treat the male chest, particularly for gynecomastia. The system is adaptable to large and small zones, making it versatile for patients with diverse body goals. When paired with devices like FaceTite or AccuTite, more delicate areas, such as the neck and submental region, can also be effectively treated.
Importantly, BodyTite is especially beneficial in areas where skin laxity coexists with stubborn fat, such as the inner thighs or lower abdomen. In such cases, patients often experience better outcomes compared to traditional liposuction.
Many practitioners combine BodyTite with Morpheus8, an RF microneedling device that further refines skin tone and texture in the same treatment areas for enhanced results.
The best candidates for BodyTite are individuals with localized fat deposits and mild to moderate skin laxity seeking a non-excisional surgery alternative. These are often patients in their 30s to 60s who are near their ideal weight but experience persistent contour issues despite diet and exercise. Skin tone is a key consideration, BodyTite delivers optimal results in those with relatively good elasticity, although it still provides measurable tightening even in moderate laxity cases.
It's beneficial for postpartum patients or individuals following weight loss who wish to address loose skin in the abdomen, arms, or thighs. Ideal candidates are in good overall health, non-smokers, and have realistic expectations regarding results and recovery. Unlike non-invasive treatments that require
multiple sessions, BodyTite offers more significant improvement in one procedure, making it attractive to those seeking efficiency and efficacy with limited downtime.
How long does a BodyTite session take, and is there any downtime afterward?
The duration of a BodyTite session depends on the number and size of treatment areas. For a single zone, such as the arms or abdomen, the procedure typically takes 60–90 minutes.
When treating multiple regions, sessions may last up to 2–3 hours.
BodyTite is usually performed under local anesthesia, with or without sedation, allowing for a comfortable and safe outpatient experience. Downtime is significantly shorter than surgical alternatives. Most patients experience swelling, bruising, and mild soreness, which subside within a few days.
Compression garments are recommended for 2–4 weeks to support healing and maximize tissue contraction. Light activities can resume within 2–3 days, while more intense physical exertion should be postponed for 1–2 weeks. The recovery process is generally smooth, and patients appreciate the balance of noticeable results with minimal interruption to daily life.
What kind of results can patients expect after undergoing the treatment, and how soon will they begin to see them?
Patients can expect visible fat reduction and significant skin tone and firmness improvement. Initial contour changes can be observed within 2–3 weeks as swelling diminishes.
However, the most pronounced results typically develop over 3 to 6 months due to ongoing collagen remodeling and dermal contraction. Radiofrequency-induced tightening continues long after the initial healing phase, delivering progressive skin texture and definition improvements. When combined with Morpheus8, the treatment further enhances results by targeting the superficial and deep dermal layers with fractional RF microneedling. This combination is especially effective in areas with visible skin laxity or textural concerns. For patients seeking a non-excisional lift with
BODYTITE’S TECHNOLOGY IS BASED ON BIPOLAR RADIOFREQUENCYASSISTED LIPOLYSIS (RFAL). IT USES A DUAL-PROBE SYSTEM, ONE INTERNAL CANNULA INSERTED UNDER THE SKIN AND ONE EXTERNAL ELECTRODE ABOVE, TO DELIVER PRECISE, FOCUSED RF ENERGY. THIS ENERGY HEATS THE ADIPOSE TISSUE AND FIBROUS SEPTAE, CAUSING ADIPOCYTE DISRUPTION AND FAT LIQUEFACTION FOR EASIER ASPIRATION.
minimal downtime, BodyTite (especially when paired with Morpheus8) provides outcomes that rival traditional surgical procedures, without the scars. Patient satisfaction is high, especially when expectations are aligned with the treatment’s capabilities.
How long do the results from BodyTite typically last, and are there any maintenance treatments needed over time?
BodyTite results are long-lasting, mainly when patients maintain a stable weight and healthy lifestyle. The fat reduction is permanent, as the adipocytes treated and aspirated do not regenerate. The skin tightening component, driven by collagen stimulation and contraction, also endures for several years.
However, natural aging and lifestyle factors, such as significant weight fluctuations or sun exposure, can influence the longevity of results. While maintenance treatments are not required, some patients opt for adjunctive procedures like Morpheus8 or Forma to support skin tone over time. These can be performed annually or bi-annually based on individual goals. Regular follow-up allows us to assess whether additional touch-ups may be beneficial. With appropriate patient selection and post-treatment care, BodyTite provides sustainable results that significantly improve both body contours and skin quality.
Is BodyTite a good option for individuals who have previously undergone other body contouring procedures?
Absolutely. BodyTite is an excellent choice for patients with prior body contouring procedures, such as liposuction or non-invasive fat reduction, but are left with residual skin laxity or contour irregularities. RFAL technology provides skin contraction and refinement that traditional methods often lack. It’s particularly beneficial in revisional cases where scar tissue or uneven fat removal has impacted the aesthetic outcome. The ability to sculpt tissue while promoting dermal tightening makes BodyTite ideal for secondary procedures. Caution is taken in areas with significant fibrosis, and energy delivery is
carefully calibrated. We also often incorporate Morpheus8 for additional surface refinement and improved skin texture, especially in areas with stretch marks or superficial irregularities. The synergy between these technologies allows us to deliver smoother, more consistent results, even in previously treated or challenging zones.
What advantages does BodyTite offer compared to other skin-tightening methods?
BodyTite offers several clinical advantages that distinguish it from other skin-tightening techniques. Firstly, it delivers a higher degree of tissue contraction, up to 40% more than liposuction alone, making it ideal for treating mild to moderate skin laxity. Its bipolar RF energy allows for simultaneous internal and external heating, offering superior precision and control. Unlike non-invasive methods that require multiple sessions and yield modest results, BodyTite typically achieves noticeable improvement in a single treatment. It also provides real-time temperature and impedance monitoring, which enhances safety and consistency. From a practitioner’s perspective, BodyTite is highly versatile and can be used across various anatomical regions with customizable settings. Combined with devices like Morpheus8, it further addresses surface irregularities, texture, and dermal rejuvenation, creating a comprehensive aesthetic result surpassing what standalone energy-based devices can achieve.
Are there any risks or side effects associated with BodyTite, and how do you mitigate these concerns during the procedure?
As with any medical procedure, BodyTite carries some risks, although they are minimal with proper technique and patient selection. Common side effects include temporary swelling, bruising, numbness, or tenderness. More rare complications may involve thermal burns, asymmetry, or seroma formation. We use real-time temperature monitoring and impedance control to mitigate risks, ensuring that RF energy remains within safe therapeutic
BODYTITE RESULTS ARE LONG-LASTING, MAINLY WHEN PATIENTS MAINTAIN A STABLE WEIGHT AND HEALTHY LIFESTYLE. THE FAT REDUCTION IS PERMANENT, AS THE ADIPOCYTES TREATED AND ASPIRATED DO NOT REGENERATE. THE SKIN TIGHTENING COMPONENT, DRIVEN BY COLLAGEN STIMULATION AND CONTRACTION, ALSO ENDURES FOR SEVERAL YEARS. HOWEVER, NATURAL AGING AND LIFESTYLE FACTORS, SUCH AS SIGNIFICANT WEIGHT FLUCTUATIONS OR SUN EXPOSURE, CAN INFLUENCE THE LONGEVITY OF RESULTS. WHILE MAINTENANCE TREATMENTS ARE NOT REQUIRED, SOME PATIENTS OPT FOR ADJUNCTIVE PROCEDURES LIKE MORPHEUS8 OR FORMA TO SUPPORT SKIN TONE OVER TIME.
ranges. The BodyTite handpiece automatically shuts off if overheating is detected, reducing the likelihood of thermal injury. In addition, we employ precise, uniform movement during treatment and avoid overlapping passes. Patient selection is key, we thoroughly assess skin quality, fat distribution, and medical history. Clear post-treatment guidelines support safe recovery, including compression garment use and activity restrictions. Overall, when performed in a professional setting with advanced safety protocols, BodyTite has an excellent safety record and consistently high patient satisfaction.
How do you tailor BodyTite treatment plans for each patient to achieve their specific body goals?
A personalized approach is essential in BodyTite treatments. Each patient begins with a comprehensive consultation, physical examination, lifestyle assessment, and medical history review. We evaluate fat distribution, degree of skin laxity, and aesthetic expectations. Based on this, we design a treatment strategy tailored to the individual’s anatomy and goals. For example, patients with significant surface irregularities may benefit from combining BodyTite with Morpheus8 to target volume and skin texture.
Energy levels, probe depth, and aspiration volume are adjusted based on treatment area and tissue response. We also set realistic timelines for recovery and result progression. Photography and, when needed, 3D imaging are used for tracking and planning. This structured, customized approach ensures the safe delivery of RF energy while achieving a harmonious, natural-looking result. Ongoing follow-up helps us monitor outcomes and recommend maintenance or adjunctive treatments if desired.
Can you describe the patient's experience during and after the procedure? Is the recovery process relatively easy for most people?
Patients typically find the BodyTite procedure comfortable and manageable. It
is performed under local anesthesia, often with light sedation, allowing for a pain-free experience without the risks of general anesthesia. During treatment, patients may feel warmth or pressure but not significant discomfort. Afterward, mild bruising, swelling, or tenderness is common and typically resolves within a few days. Most patients can return to work and their daily routines within 2–3 days. Compression garments are worn to support healing and optimize skin tightening. The overall recovery process is relatively easy, particularly compared to surgical options like abdominoplasty or Brachioplasty. Patients appreciate the minimal downtime and visible improvements in contour and skin tone. Followup appointments are scheduled to assess healing and provide support. In clinical practice, most patients express high satisfaction with the process and outcomes, particularly when adequately educated about the procedure.
What advice would you give someone considering BodyTite as a non-invasive body contouring and fat reduction option?
While BodyTite is minimally invasive, it delivers results that are far superior to those of noninvasive treatments.
I would suggest that you clearly understand its capabilities and limitations. It’s best suited for patients who seek noticeable fat reduction with simultaneous skin tightening, but wish to avoid scars and prolonged downtime. Consult with a qualified practitioner with experience with RFAL and a strong understanding of body aesthetics. Ask about the potential to combine BodyTite with complementary technologies like Morpheus8, which can enhance skin texture and long-term outcomes.
Be prepared for a few days of downtime, and follow post-care instructions diligently to ensure optimal results. Most importantly, maintain realistic expectations, while BodyTite can produce transformative results, it is not a substitute for major surgical interventions when indicated. For the right candidate, however, it offers an exceptional balance of efficacy, safety, and minimal invasiveness.
BODYTITE OFFERS SEVERAL CLINICAL ADVANTAGES THAT DISTINGUISH IT FROM OTHER SKIN-TIGHTENING TECHNIQUES. FIRSTLY, IT DELIVERS A HIGHER DEGREE OF TISSUE CONTRACTION, UP TO 40% MORE THAN LIPOSUCTION ALONE, MAKING IT IDEAL FOR TREATING MILD TO MODERATE SKIN LAXITY. ITS BIPOLAR RF ENERGY ALLOWS FOR SIMULTANEOUS INTERNAL AND EXTERNAL HEATING, OFFERING SUPERIOR PRECISION AND CONTROL. UNLIKE NON-INVASIVE METHODS THAT REQUIRE MULTIPLE SESSIONS AND YIELD MODEST RESULTS, BODYTITE TYPICALLY ACHIEVES NOTICEABLE IMPROVEMENT IN A SINGLE TREATMENT.
Gastrointestinal diseases, particularly those affecting the bile ducts and pancreas, often present diagnostic and therapeutic challenges due to the anatomical complexity and inaccessibility of the hepatobiliary system. Over the past decades, Endoscopic Retrograde Cholangiopancreatography (ERCP) has become a cornerstone in managing these disorders. However, traditional ERCP relies heavily on fluoroscopic imaging, which limits direct visualization inside the biliary and pancreatic ducts. Today, Al-Ahli Hospital in Doha, Qatar, is redefining this standard through the integration of the SPYGLASS™ Direct Visualization System, a breakthrough in cholangioscopy and interventional endoscopy. Under the expertise of Dr. Alaa Taha, Consultant Gastroenterologist, this technology has elevated diagnostic accuracy and therapeutic efficiency to new heights, positioning Al-Ahli Hospital as a center of excellence for advanced hepatobiliary care.
The SPYGLASS™ DS (Digital System) is a stateof-the-art cholangioscope that provides direct, high-definition visual access to the biliary and pancreatic ductal systems. Unlike conventional ERCP, which relies on indirect imaging via X-rays and contrast, the SPYGLASS™ system features a fiber-optic probe with a miniature digital camera that allows endoscopists to see inside the ducts in real time, offering unparalleled precision. This enables clinicians to:
• Accurately diagnose indeterminate strictures and biliary lesions
• Target and retrieve intricate ductal stones
• Perform guided biopsies with greater confidence
• Treat complex disorders without the need for open surgery
“The clarity, maneuverability, and diagnostic certainty the SPYGLASS™ system provides are exceptional,” says Dr. Alaa Taha. “We now make faster and more informed decisions that directly impact patient outcomes.”
Indications: When Advanced ERCP with SPYGLASS™ Is Used
Dr. Taha highlights that SPYGLASS™-assisted ERCP is particularly valuable in complex and ambiguous clinical cases where traditional methods fall short. These include:
• Unexplained bile duct strictures
• (to differentiate between benign and malignant causes)
• Primary sclerosing cholangitis
• (to monitor for dysplasia or cancer)
• Cholangiocarcinoma or biliary tumors
• Difficult bile duct stones
• (especially in intrahepatic or narrow ducts)
• Recurrent pancreatitis or pancreatic duct stones
Through direct visualization, lesions can be biopsied with high yield, and targeted therapies such as laser lithotripsy or electrohydraulic stone fragmentation can be administered with pinpoint accuracy.
One of the most profound impacts of the SPYGLASS™ system is on patient experience. Traditional diagnostics such as MRCP or CT often leave clinicians uncertain, leading to multiple procedures or unnecessary surgeries. SPYGLASS™ changes this by allowing both diagnosis and treatment in a single session. Key patient benefits include:
• Minimally invasive intervention
• Shorter procedure time and recovery
• Lower complication rates
• Outpatient or short-stay suitability
• Avoidance of unnecessary major surgery
Patients at Al-Ahli Hospital report quicker returns to normal life, lower anxiety from waiting
on uncertain diagnoses, and better overall satisfaction due to the clarity and effectiveness of the procedure.
Dr. Taha recalls a case involving a 47-year-old patient with a history of abdominal discomfort and abnormal liver function tests. An MRCP revealed a suspected stricture, but no conclusive evidence of malignancy. Using SPYGLASS™, Dr. Taha was able to visualize a suspicious mass, perform a targeted biopsy, and confirm early-stage cholangiocarcinoma. “Without SPYGLASS™, we might have missed the window for early diagnosis. The patient underwent curative treatment and is now under surveillance with an excellent prognosis,” Dr. Taha shares.
Implementing such advanced technologies requires not just state-of-the-art equipment, but also well-trained professionals, rigorous safety protocols, and a patient-centered philosophy. Al-Ahli Hospital is proud to be at the forefront, combining world-class medical technology with highly skilled specialists like Dr. Taha. His expertise, built on years of experience and international training, ensures that each procedure is performed with technical mastery and compassionate care. The hospital also follows stringent infection control protocols, continuous monitoring, and post-procedure follow-up to ensure optimal safety and longterm outcomes.
By adopting SPYGLASS™ as part of its advanced interventional endoscopy suite, Al-Ahli Hospital has positioned itself as a regional referral center for hepatobiliary cases. The institution is recognized for embracing precision
THE SPYGLASS™ DS (DIGITAL SYSTEM) IS A STATE-OF-THE-ART CHOLANGIOSCOPE THAT PROVIDES DIRECT, HIGHDEFINITION VISUAL ACCESS TO THE BILIARY AND PANCREATIC DUCTAL SYSTEMS. UNLIKE CONVENTIONAL ERCP, WHICH RELIES ON INDIRECT IMAGING VIA X-RAYS AND CONTRAST, THE SPYGLASS™ SYSTEM FEATURES A FIBER-OPTIC PROBE WITH A MINIATURE DIGITAL CAMERA THAT ALLOWS ENDOSCOPISTS TO SEE INSIDE THE DUCTS IN REAL TIME, OFFERING UNPARALLELED PRECISION.
Prosthetic surgeries are one of the most significant advancements in modern medicine. These operations enable millions of patients to regain their freedom of movement and live pain-free lives. They are performed on approximately 2.5 million people worldwide every year. However, we at Acıbadem Healthcare Group know that prosthesis surgeries carry a risk of infection like any other surgical procedure. This risk affects 1 to 3 out of every 100 patients and poses a critical threat to patient safety and successful recovery. Acıbadem employs a multidisciplinary approach and the most advanced technology to ensure the highest level of infection control safety after prosthesis surgery, both in Türkiye and internationally.
One indicator of Acıbadem's leadership in this field is the 3rd International Orthopedic Infections Consensus Meeting, which was
hosted by the Acıbadem University International Joint Center (IJC) in Istanbul. This event brought together 1,200 specialists in prosthetic surgery and infectious diseases from around the world. During the meeting, the prevention, diagnosis, and treatment of prosthetic infections were thoroughly discussed based on scientific data. Prof. Dr. Javad Parvizi, an orthopedic and traumatology specialist from the IJC, mentored the meeting. He has published more than 700 scientific articles in the field of orthopedic surgery. Prof. Parvizi summarized the purpose of the meeting, saying, "A new roadmap was created to prevent infections." It is believed that the decisions made at this consensus meeting, which addressed approximately 400 questions, will improve the success rate of prosthetic surgery by minimizing the risk of infection and enhancing patients' quality of life and satisfaction with treatment. Professor Parvizi emphasized that the previous two meetings had been held in the United States and that it was a great success for the third
THIS EVENT BROUGHT TOGETHER 1,200 SPECIALISTS IN PROSTHETIC SURGERY AND INFECTIOUS DISEASES FROM AROUND THE WORLD. DURING THE MEETING, THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PROSTHETIC INFECTIONS WERE THOROUGHLY DISCUSSED BASED ON SCIENTIFIC DATA.
meeting to be held outside the United States for the first time, in Istanbul, Türkiye. The results of this meeting will be published digitally as a scientific reference for experts.
At Acıbadem Healthcare Group, we have a comprehensive strategy to minimize the risk of infection during prosthesis surgery and provide quick, effective solutions for any infections that may occur. Our strategy is based on our expert and experienced physician staff.
Prof. Dr. Remzi Tözün emphasizes the importance of appropriate patient selection and risk management in prosthetic surgery. He states that factors such as uncontrolled diabetes or heavy smoking can increase the risk of infection two to three times. He states that the preoperative conditions of these patients should be optimized and that patients with such risk factors are meticulously evaluated at Acıbadem, where necessary precautions are taken. He also adds that, thanks to developing techniques, prostheses now last up to 30 years and patients recover faster.
Prof. Dr. İbrahim Tuncay pointed out that infectious diseases are an important problem today and stated that even microorganisms that were discussed at the consensus meeting can
cause prosthesis infections. He stated that there are at least 25,000 to 30,000 cases of infection after prosthesis surgery worldwide each year and emphasized the importance of factors such as the patient's chronic diseases, the hospital environment, and the correct implementation of infection control measures. He pointed out that unconscious antibiotic use is one of the biggest risks in developing an infection and warned that unnecessary antibiotic use can mask an infection and lead to antibiotic resistance. At Acıbadem, a responsible, scientifically justified approach to antibiotic use is taken.
Under the leadership of Prof. Dr. Parvizi, a world authority on prosthetic infections, Acıbadem applies the most up-to-date scientific approaches to infection control. His participation in international consensus meetings demonstrates Acıbadem's global impact in this field.
Acıbadem's success in preventing infections
THE PREVENTION AND TREATMENT OF INFECTIONS IN PROSTHETIC SURGERY IS CRUCIAL FOR BOTH SURGICAL SUCCESS AND THE PATIENT'S LONG-TERM QUALITY OF LIFE. WITH ITS LEADING PHYSICIANS, STATE-OF-THE-ART TECHNOLOGY, AND MULTIDISCIPLINARY APPROACH, ACIBADEM HEALTHCARE GROUP IS COMMITTED TO PROVIDING PATIENTS WITH SUCCESSFUL SURGERIES AND COMPLETE SAFETY AND COMFORT DURING THE POSTOPERATIVE PERIOD. YOUR HEALTH IS OUR PRIORITY, AND WE WILL BE WITH YOU EVERY STEP OF THE WAY ON YOUR JOURNEY TO RECOVERY.
spans from patient selection to post-discharge follow-up and includes intraoperative practices. Preoperative screening, individualized antibiotic protocols, and postoperative follow-up programs reduce the risk of infection based on scientific principles.
However, thanks to the emphasis on patient education, patients can play an active role in managing their health. This approach positively affects short- and long-term results and quality of life.
The prevention and treatment of infections in
prosthetic surgery is crucial for both surgical success and the patient's long-term quality of life. With its leading physicians, state-of-the-art technology, and multidisciplinary approach, Acıbadem Healthcare Group is committed to providing patients with successful surgeries and complete safety and comfort during the postoperative period. Your health is our priority, and we will be with you every step of the way on your journey to recovery.
AT ACIBADEM HEALTHCARE GROUP, WE HAVE A COMPREHENSIVE STRATEGY TO MINIMIZE THE RISK OF INFECTION DURING PROSTHESIS SURGERY AND PROVIDE QUICK, EFFECTIVE SOLUTIONS FOR ANY INFECTIONS THAT MAY OCCUR. OUR STRATEGY IS BASED ON OUR EXPERT AND EXPERIENCED PHYSICIAN STAFF.
Mahafzah,
Rhinoplasty, or nose reshaping surgery, is a complex yet elegant surgical procedure that sits at the intersection of medicine and art. While often pursued for cosmetic refinement, its therapeutic and health-oriented benefits are equally crucial. At Al-Ahli Hospital, we strive to educate patients that rhinoplasty is not merely an aesthetic choice, it is, for many, a pathway to improved breathing, comfort, and confidence. Dr. Tareq Mahafzah, Consultant ENT and Head of Department, shares his insights into this transformative surgery and how it balances form and function.
The nose is not only central to one’s facial aesthetics but is also a vital organ responsible for warming, humidifying, and filtering inhaled air. Its internal structures contribute to voice resonance, olfactory perception, and respiratory health. A nasal deformity, whether congenital or caused by trauma, can significantly affect these functions. Rhinoplasty, therefore, isn’t simply cosmetic; it may be a necessary intervention to restore optimal breathing or correct structural damage. Dr. Mahafzah explains: “Patients often present with a combination of concerns: a dorsal hump they dislike aesthetically and a deviated septum that hinders their breathing. A good surgeon doesn’t just choose between beauty and function, he integrates both.”
Patients pursue rhinoplasty for various reasons: some seek to harmonize their facial profile, others to alleviate chronic nasal obstruction. Cultural influences, peer feedback, personal insecurities, or post-trauma changes may all shape a patient’s desire for change.
“At Al-Ahli Hospital, we encourage an
honest, open conversation,” Dr. Mahafzah says. “We explore the patient’s expectations, assess their nasal anatomy, and determine whether aesthetic reshaping, functional correction, or a combination is required.”
A careful consultation is the cornerstone of a successful rhinoplasty outcome. This includes a complete ENT evaluation, discussion of the patient’s goals, psychological preparedness, and digital imaging to simulate possible outcomes.
Functional rhinoplasty targets issues like septal deviation, turbinate hypertrophy, nasal valve collapse, and chronic sinusitis. Many patients struggle for years with nasal congestion, snoring, or headaches without realizing the cause is structural. “Rhinoplasty can dramatically improve quality of life,” Dr. Mahafzah states. “Better airflow improves sleep, oxygen saturation, energy levels, and even sports performance. Many patients notice they breathe more easily within days of surgery.” Combining septoplasty (correcting the nasal septum) with rhinoplasty is common. The goal is to preserve or enhance nasal structure while reshaping the external appearance, a delicate but rewarding task.
In aesthetic rhinoplasty, patients often want to address concerns such as a prominent hump, bulbous tip, crooked bridge, or asymmetry. However, Dr. Mahafzah warns against a onesize-fits-all mentality.
“Every face is unique,” he says. “We do not apply Western ideals to Middle Eastern faces. Instead, we strive for natural harmony, maintaining ethnic identity while enhancing balance.”
Al-Ahli Hospital employs advanced 3D planning tools and state-of-the-art equipment to ensure precision. This includes closed (endonasal) or open rhinoplasty, depending on the complexity of the case.
What makes rhinoplasty different from other procedures is its duality, it’s deeply medical and profoundly artistic. The surgeon must possess an understanding of facial aesthetics, proportion, and harmony, while mastering anatomy and surgical technique.
“No two rhinoplasties are the same,” says Dr. Mahafzah. “You’re not just changing a nose. You’re changing how someone feels about themselves, how they breathe, how they face the world. That’s a huge responsibility.”
Surgeons must also account for the healing process. Swelling may take months to subside. Cartilage memory and scar tissue can influence long-term outcomes. Precision and patience are essential.
In the Middle East, where appearances carry deep social and personal significance, cosmetic surgery must be approached with sensitivity. Education is key. “We guide our patients with honesty,” Dr. Mahafzah adds. “We don’t overpromise. We explain risks, set realistic expectations, and support them during recovery.” At Al-Ahli Hospital, postoperative care includes regular follow-ups, monitoring for complications, and offering emotional support to patients who may experience temporary swelling or bruising.
Successful rhinoplasty achieves more than just a beautiful nose, it improves selfesteem, breathing, and overall wellness. It is a transformative procedure that blends art, anatomy, and empathy. For Dr. Mahafzah and the ENT team at Al-Ahli Hospital, every surgery is a chance to improve a life, not just a face.
www.ahlihospital.com
THE NOSE IS NOT ONLY CENTRAL TO ONE’S FACIAL AESTHETICS BUT IS ALSO A VITAL ORGAN RESPONSIBLE FOR WARMING, HUMIDIFYING, AND FILTERING INHALED AIR. ITS INTERNAL STRUCTURES CONTRIBUTE TO VOICE RESONANCE, OLFACTORY PERCEPTION, AND RESPIRATORY HEALTH. A NASAL DEFORMITY, WHETHER CONGENITAL OR CAUSED BY TRAUMA, CAN SIGNIFICANTLY AFFECT THESE FUNCTIONS RHINOPLASTY, THEREFORE, ISN’T SIMPLY COSMETIC; IT MAY BE A NECESSARY INTERVENTION TO RESTORE OPTIMAL BREATHING OR CORRECT STRUCTURAL DAMAGE.
diagnostics, investing in continuous medical education, and fostering innovation across all departments. It is also playing a role in educating local and regional physicians about the possibilities of cholangioscopy, hosting workshops, symposiums, and live procedure demonstrations, further reinforcing its role as a leader in minimally invasive medicine.
As technology evolves, the SPYGLASS™ system is expected to expand its indications further, potentially integrating with AI-assisted diagnostics, robotic navigation, and real-time pathology tools. Dr. Taha and his team at Al-Ahli Hospital are already engaged in data collection and clinical audits to evaluate procedural outcomes, patient satisfaction, and diagnostic yield, aiming to contribute to regional and international gastroenterology literature.
“Innovation must always serve patient care. That’s our philosophy,” Dr. Taha concludes.
The integration of SPYGLASS™ technology at Al-Ahli Hospital marks a pivotal shift in how gastroenterological conditions are diagnosed and managed.
Patients no longer need to navigate uncertainty, undergo repeated imaging, or face the risks of exploratory surgery.
With direct visualization, targeted therapy, and faster recovery, the future of biliary and pancreatic care is here, and it is crystal clear.
For those seeking accurate, minimally invasive, and world-class care, Al-Ahli Hospital remains the destination of choice, with Dr. Alaa Taha leading the way in excellence and innovation.
AS TECHNOLOGY EVOLVES, THE SPYGLASS™ SYSTEM IS EXPECTED TO EXPAND ITS INDICATIONS FURTHER, POTENTIALLY INTEGRATING WITH AI-ASSISTED DIAGNOSTICS, ROBOTIC NAVIGATION, AND REAL-TIME PATHOLOGY TOOLS. DR. TAHA AND HIS TEAM AT AL-AHLI HOSPITAL ARE ALREADY ENGAGED IN DATA COLLECTION AND CLINICAL AUDITS TO EVALUATE PROCEDURAL OUTCOMES, PATIENT SATISFACTION, AND DIAGNOSTIC YIELD, AIMING TO CONTRIBUTE TO REGIONAL AND INTERNATIONAL GASTROENTEROLOGY LITERATURE.
S a u d i M e d t e c h 2 0 2 5 R i y a d h , S a u d i A r a b i a 2 0 2 5 ﺔ
S t e p i n t o t h e F u t u r e o f H e a l t h c a r e
C o n n e c t e d , I n t e l l i g e n t a n d P e r s o n a l i s e d
Health Leaders
Dr. Reem AlBunyan Chief Executive Officer Value in Health Saudi Arabia
R e g i s t e r N o w 1 7 1 8 2 0 2 5
blic Health and Health Informatics K S A U H S , R i y a d h , S a u d i A r a b i a
September 18-21, 2025
Visit healthexpoiraq.iq to find out all country pavilions participating.
Iraq stands at a pivotal moment in its healthcare journey. With unprecedented government investment, ambitious national healthcare programs, and a commitment to modernization, the opportunities are extraordinary. Health Expo Iraq 2025 is your gateway to this transformative market Alongside the Exhibition, As we celebrate our milestone 5th edition, we’ve evolved from an exhibition into the region’s most influential healthcare platform -where policy meets innovation, where partnerships are forged, and where the future of Iraqi healthcare takes shape.
Comprehensive Healthcare Showcase :
• Pharmaceuticals & Medications
• Hospital Build & Infrastructure
• Healthcare IT & Digital Solutions
• Specialized Care & Services
• Medical Supplies consumables
• Medical Equipment & Devices
• Education & Training
+300
Leading Exhibitors
9
National Pavilion
+25
Participating Countries
+18K
Professional Visitors
+35 Delegates
serves as a strategic platform, bringing together health leaders, decision-makers, and experts from both the
Private hospitals across Iraq are working to enhance healthcare services and expand their capacity to meet the growing needs of citizens. These efforts align with the Iraqi government’s directives to strengthen the health sector, support the implementation of health insurance, and encourage greater integration between the private and public sectors. With the direct support of His Excellency the Prime Minister, Mr. Muhammed Shiaa Al-Sudani, and in coordination with the Iraqi Ministry of Health, private healthcare institutions aim to provide high-quality medical services and contribute to building a more sustainable and accessible healthcare system for all Iraqis.
Laboratory safety is a comprehensive, essential system composed of meticulously designed protocols and standardized procedures. Its primary purpose is to prevent accidents, occupational injuries, and illnesses associated with laboratory environments, whether in research, medical, industrial, or educational settings.
More than just a set of rules, laboratory safety represents a workplace culture rooted in attention to detail. It begins with proper use of personal protective equipment (PPE), such as gloves, lab coats, and safety goggles, and extends to the cautious handling of hazardous substances, including chemical, biological (e.g., bacteria and viruses), and radiological materials.
Effective safety practices are vital not only for protecting laboratory personnel and visitors but also for ensuring the accuracy of research data and preventing environmental contamination.
PPE serves as the first line of defense in safeguarding laboratory staff. Lab coats provide a protective barrier for skin and clothing against chemical or biological splashes. Gloves, selected based on material compatibility such as nitrile or latex, are critical for hand protection. Safety goggles or face shields protect the eyes from splashes or airborne debris. In environments with harmful vapors or fine airborne particles, respiratory protection becomes essential to ensure safe air quality. Consistent and correct use of PPE is fundamental to maintaining a safe and healthy working environment.
Laboratory safety is a foundation for multiple essential areas.
The foremost goal of any safety system is to safeguard lives and minimize risk. In laboratories where individuals interact with potentially harmful materials, protection is especially crucial. Well-implemented safety protocols help:
• Prevent direct injuries, such as cuts from broken glass, chemical burns, or slips and falls
• Minimize exposure to hazardous substances through proper ventilation and use of fume hoods
• Reduce risk of biological infections via sterilization, safe specimen handling, and proper disposal of biohazardous waste
• Ensure radiological safety in labs working with radioactive materials through shielding, dosimetry, and exposure monitoring
Laboratories operate within a rigorous legal framework requiring adherence to established safety standards, both nationally and internationally.
• OSHA Standards: In the United States, the Occupational Safety and Health Administration (OSHA) enforces detailed safety regulations in laboratory settings, including routine inspections for compliance
• The Joint Commission: This global accreditation body for healthcare facilities includes strict standards for laboratory safety for staff and patients alike
• Legal Responsibility: Non-compliance can lead to severe consequences such as financial penalties, operational shutdowns, and even legal action if negligence results in injury or harm. Adhering to regulations significantly reduces an institution’s legal and financial risk
Laboratory accidents disrupt operations and productivity, with consequences extending beyond physical harm.
• Downtime: Lab activities may halt while incidents are investigated, cleaned up, and remediated
• Injury and Damage Costs: Medical expenses, worker compensation, equipment repair or replacement, and reputational damage all carry financial burden
• Loss of Research: Accidents can destroy
PPE SERVES AS THE FIRST LINE OF DEFENSE IN SAFEGUARDING LABORATORY STAFF. LAB COATS PROVIDE A PROTECTIVE BARRIER FOR SKIN AND CLOTHING AGAINST CHEMICAL OR BIOLOGICAL SPLASHES. GLOVES, SELECTED BASED ON MATERIAL COMPATIBILITY SUCH AS NITRILE OR LATEX, ARE CRITICAL FOR HAND PROTECTION. SAFETY GOGGLES OR FACE SHIELDS PROTECT THE EYES FROM SPLASHES OR AIRBORNE DEBRIS. IN ENVIRONMENTS WITH HARMFUL VAPORS OR FINE AIRBORNE PARTICLES, RESPIRATORY PROTECTION BECOMES ESSENTIAL TO ENSURE SAFE AIR QUALITY. CONSISTENT AND CORRECT USE OF PPE IS FUNDAMENTAL TO MAINTAINING A SAFE AND HEALTHY WORKING ENVIRONMENT.
samples, corrupt data, or damage vital instruments, severely delaying scientific progress.
• Workplace Morale: A safe environment fosters confidence and focus among staff, enhancing performance and overall lab efficiency.
In essence, laboratory safety is a strategic investment in people, scientific accuracy, and operational sustainability, making it indispensable in any modern lab setting.
A safe, effective lab environment begins with a structured, proactive approach to risk identification and mitigation. Laboratories naturally present a wide range of potential hazards, requiring constant vigilance and a thorough understanding of threats. These risks span multiple domains, each requiring specific control strategies.
Chemicals are integral to laboratory work but pose serious risks if mishandled. These include exposure to toxic substances that may harm the respiratory, nervous, or internal organ systems. Safe storage, proper ventilation, and appropriate PPE are necessary to manage these risks effectively.
Life sciences, medical, and microbiology labs face heightened risks from pathogens such as bacteria, viruses, fungi, and parasites. Handling these organisms demands compliance with biological containment levels (BSL-1 to BSL-4), sterilization protocols, and secure waste disposal to prevent infection.
Often underestimated, physical hazards remain a leading cause of laboratory accidents. These include sharp instruments like needles, scalpels, or microtome blades. Preventative measures include safe handling, proper organization, and prompt cleanup of spills.
Labs using radioactive materials for research or diagnostics must address ionizing radiation (gamma rays, X-rays, alpha, beta) and nonionizing radiation (UV, lasers, microwaves). Safety requires shielding, dose monitoring, and training.
High-pressure and high-temperature equipment present additional risks. Pressurized gas cylinders, such as those containing nitrogen, hydrogen, or oxygen, can explode if damaged or overheated. High-speed centrifuges may fail if unbalanced. Autoclaves, used for steam sterilization, pose burn and explosion risks. These tools require routine maintenance, operator training, and strict adherence to manufacturer guidelines.
Risk control starts with identifying hazards, analyzing materials, procedures, and equipment, and documenting risks and mitigation steps clearly in SOPs. SOPs must be accessible and understandable to all. A strong safety culture is vital, with safety awareness integrated into daily routines. Everyone shares responsibility for safety, fostering a laboratory environment of responsibility, collaboration, and care.
A SAFE, EFFECTIVE LAB ENVIRONMENT BEGINS WITH A STRUCTURED, PROACTIVE APPROACH TO RISK IDENTIFICATION AND MITIGATION. LABORATORIES NATURALLY PRESENT A WIDE RANGE OF POTENTIAL HAZARDS, REQUIRING CONSTANT VIGILANCE AND A THOROUGH UNDERSTANDING OF THREATS. THESE RISKS SPAN MULTIPLE DOMAINS, EACH REQUIRING SPECIFIC CONTROL STRATEGIES.
Ovasave, a Hub71 FemTech startup focused on fertility and hormonal health, has successfully completed its pre-seed round, raising $1.2 million from a mix of regional and international investors. The round was led by PlusVC, Annex Investments, and New York-based 25 Madison, with additional backing from UAE and Saudi-based strategic angel investors and prominent family offices. This reflects the strong investors’ confidence and growing demand for innovation in women’s health across the region.
OVASAVE OFFERS WOMEN A SEAMLESS, DIGITAL-FIRST EXPERIENCE FOR FERTILITY TESTING, EGG FREEZING, HORMONE MANAGEMENT, AND MENOPAUSE CARE.
Founded in 2023, Ovasave offers women a seamless, digital-first experience for fertility testing, egg freezing, hormone management, and menopause care. The platform combines at-home hormone testing, virtual consultations, personalized supplement protocols, and access to top fertility clinics for fertility preservation (egg freezing). Positioned as disruptors in fertility and women’s hormonal health, Ovasave has also established a growing corporate benefits scheme that helps organizations support employees’ reproductive health as part
of their workplace wellbeing programs.
The $1.2m capital raised will be used to support regional expansion across the GCC, scale corporate partnerships, and launch the next phase of Ovasave’s mobile app, which will include menstrual cycle tracking, symptom monitoring, access to care, and AI-driven treatment protocols. Ovasave will also address a historically overlooked stage of women’s health, offering a broader range of services targeting perimenopause and menopause.
The raise comes as the UAE accelerates national reforms in healthcare and women’s rights, offering a timely window for FemTech innovation. Ovasave is registered with the Department of Health – Abu Dhabi and supported by Abu Dhabi’s global tech ecosystem, Hub71, further aligning it with the nation’s broader digital and preventive health strategies.
Majd Abu Zant, Co-founder of Ovasave and global leader in fertility and women’s healthcare, “Abu Dhabi’s focus on innovation, healthcare, and entrepreneurship has created a competitive environment for founders and investors alike. As an Abu Dhabi-based startup supported by Hub71, Ovasave has benefited from a strong regulatory framework, access to capital, and proximity to regional decisionmakers. It’s the right environment to build and scale high-impact ventures, and from here, we are expanding into Saudi Arabia and the wider MENA region.”
A recent report by FemTech Analytics (FTA) revealed that the FemTech market in the MENA region is projected to reach $3.8 billion by 2031, growing at a CAGR of 15% during the forecast period from 2021 to 2031. (source: FTA Study, 2021)
“Overall, FemTech in the UAE is still in its early stages, but the momentum is clear. With increasing investor interest and a strong national focus on women’s health and innovation, the UAE is emerging as a regional hub for the growth of this sector,” Abu Zant added.
Torkia Mahloul, Co-founder and CEO of Ovasave said, "There is a critical need for timely
intervention in women’s health, particularly around fertility and hormonal health. This funding marks a crucial step in our mission to disrupt women’s health and expand access to fertility and hormonal care across the region. We are grateful for the confidence shown by our investors, which allows us to scale a platform designed to deliver timely, personalized, and accessible fertility and hormonal care. By bringing together medical expertise, digital convenience, and emotional support, we are helping women take control of their health earlier and more effectively across different life stages.”
Built with a clear purpose, Ovasave is shifting women’s care from reactive to proactive. Its solutions are designed to reduce costs, improve outcomes, and make it easier for women to access support in an area that has long been considered taboo and under-discussed. Moreover, Ovasave has embedded public education into its core mission, organizing awareness events, expert talks, and collaborating with physicians to normalize fertility conversations. One of its standout initiatives was the “Fertility Your Way” campaign with Merck Gulf, offering free AMH screenings across the UAE. More than 500 women were screened during the campaign. The startup also partnered with leading employers including Aldar, Boston Consulting Group, and WeWork to raise awareness on fertility in the workplace. Through these efforts, Ovasave is helping shift the narrative on reproductive health across the region.
"With investor confidence and strong market demand, the conversation around women’s health is changing, signaling that fertility and hormonal care are no longer peripheral issues. Women’s health is now a priority for innovation and investment in the Middle East, and we are proud to be leading that change,” Mahloul concluded.
Ovasave’s fundraising comes amid growing investor interest in women’s health and fertility innovation across the MENA region. With a $1.2M pre-seed round now closed, Ovasave is expanding operations to Saudi Arabia this summer, with broader regional growth across MENA being part of their 3-year expansion strategy.
THE $1.2M CAPITAL RAISED WILL BE USED TO SUPPORT REGIONAL EXPANSION ACROSS THE GCC, SCALE CORPORATE PARTNERSHIPS, AND LAUNCH THE NEXT PHASE OF OVASAVE’S MOBILE APP, WHICH WILL INCLUDE MENSTRUAL CYCLE TRACKING, SYMPTOM MONITORING, ACCESS TO CARE, AND AIDRIVEN TREATMENT PROTOCOLS. OVASAVE WILL ALSO ADDRESS A HISTORICALLY OVERLOOKED STAGE OF WOMEN’S HEALTH, OFFERING A BROADER RANGE OF SERVICES TARGETING PERIMENOPAUSE AND MENOPAUSE.
By Ali Elhaj, LLM., Ph. D. Healthcare CEO, Board Member. Risk Governance, Forecast. Implementation. Advisor and Strategist.
Unprecedented medical breakthroughs define our century; gene therapies that cure once-fatal diseases, AI-powered diagnostics that predict illnesses before symptoms appear, and surgical robots that perform with super precision. Yet, despite these discoveries, healthcare remains an afterthought in political agendas, often overshadowed by infrastructure, defense, or economic policies. The bitter irony? A nation’s true wealth is measured by the health of its people.
Healthcare isn’t just hospitals nurses, doctors, and administrators; it’s a fragile
HEALTHCARE ISN’T JUST HOSPITALS NURSES, DOCTORS, AND ADMINISTRATORS; IT’S A FRAGILE ECOSYSTEM OF FUNDING, ETHICS, WORKFORCE, TECHNOLOGY, AND GOVERNANCE.
ecosystem of funding, ethics, workforce, technology, and governance. When one-piece falters, the entire system crumbles. We’ve seen it before: pandemics that expose brittle supply chains, mental health crises ignored until they explode into homelessness and addiction, rural communities left without basic care while urban centers thrive. Progress means nothing if it isn’t equitable, sustainable, or accessible.
Yes, we’ve conquered diseases that once wiped-out millions. Yes, life expectancy has risen in many parts of the world. But these victories mask a dangerous complacency.
For every milestone, there’s a hidden failure:
• Technology without access: Cuttingedge treatments exist, but who can afford them? A diabetic in first-world countries rations insulin, while a farmer in thirdworld countries dies from a lack of basic antibiotics.
• Workforce burnout: Doctors and nurses, the backbone of care, are leaving in masses, exhausted, underpaid, and disillusioned.
• Fragmented systems: A patient with cancer might survive the disease only to be bankrupted by it. A mental health patient slips through the cracks because psychiatry isn’t "as urgent" as cardiology.
We’ve optimized for innovation but neglected fairness. We’ve built amazing hospitals in cities while clinics in poor areas struggle to keep the lights on.
When healthcare isn’t a priority, society pays in ways that don’t always make headlines:
A sick workforce is an unproductive one. Chronic illnesses, untreated mental health conditions, and preventable diseases drain economies. The World Health Organization estimates that for every dollar invested in healthcare, there’s a $4 return in productivity. Yet governments still treat it as an expense rather than an investment.
Health inequity breeds resentment. When people see that wealth determines who lives and who dies, trust in institutions erodes. The opioid crisis, maternal mortality rates among marginalized groups, and vaccine disparities during COVID-19 weren’t just tragedies; they were political failures that deepened divides.
3. The Next Pandemic Will Be Worse COVID-19 was a stress test, and most healthcare
systems failed. Shortages of PPE, ICU beds, and medical staff weren’t unforeseeable; they were the result of years of reprioritization. Calling healthcare a "priority" isn’t about empty slogans. It requires:
• Funding that matches the need: Not just more money, but smarter allocation. Why do we spend fortunes on late-stage disease treatment but skimp on prevention? Remember, prevention costs money, too!
• Workforce support: better pay, better working conditions, and realistic patientto-staff ratios. No algorithm can replace a healthcare provider's humanistic touch.
• Integration of services: Mental health can’t be an afterthought. Primary care shouldn’t be a luxury. Technology should bridge gaps, not widen them.
• Political courage: Reregulating drug prices, taxing unhealthy drinks, and investing in rural healthcare aren’t popular, but they save lives.
A Healthy Society Isn’t a Luxury, It’s the Foundation.
We accept that infrastructure and national security require long-term planning. Why not healthcare and education? A nation with crumbling hospitals and deteriorating schools but gleaming highways is a nation in denial.
The blunt truth is, we know how to fix this. Universal healthcare models, preventive care emphasis, and fair drug pricing aren’t utopian fantasies; they’re proven strategies. What’s missing is the will to treat health as the nonnegotiable right it should be, just like security.
The next time a politician and economist call healthcare "too expensive," ask them: What’s the cost of letting people suffer? What’s the price of a broken system? The answer is simple: we’re paying it already, in lives, in stability, in human potential. Pretending healthcare is just another line item is intentional misery or fatal denial. Healthcare is the backbone of everything else. And until we treat it that way, we’re all living on borrowed time.
THE NEXT TIME A POLITICIAN AND ECONOMIST CALL HEALTHCARE "TOO EXPENSIVE," ASK THEM: WHAT’S THE COST OF LETTING PEOPLE SUFFER? WHAT’S THE PRICE OF A BROKEN SYSTEM? THE ANSWER IS SIMPLE: WE’RE PAYING IT ALREADY, IN LIVES, IN STABILITY, IN HUMAN POTENTIAL. PRETENDING HEALTHCARE IS JUST ANOTHER LINE ITEM IS INTENTIONAL MISERY OR FATAL DENIAL. HEALTHCARE IS THE BACKBONE OF EVERYTHING ELSE. AND UNTIL WE TREAT IT THAT WAY, WE’RE ALL LIVING ON BORROWED TIME.
Our experts get to know you, then tailor treatments to help fit your needs—which could include radiation, surgery, chemotherapy, immunotherapy, cellular therapy, genetic counseling, or a customized lifestyle management plan. In collaboration with Baylor College of Medicine, we’re equipped to pave the way for even more revolutionary discoveries and groundbreaking approaches to cancer prevention, diagnosis, and treatment.
Learn more about the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine at stlukeshealth.org/bslmcinternational
